Identification and characterization of genes responsible for high persistence in Salmonella enterica serovar Typhimurium by Victorsen, Alec DeMars Houlihan
Retrospective Theses and Dissertations Iowa State University Capstones, Theses andDissertations
2008
Identification and characterization of genes
responsible for high persistence in Salmonella
enterica serovar Typhimurium
Alec DeMars Houlihan Victorsen
Iowa State University
Follow this and additional works at: https://lib.dr.iastate.edu/rtd
Part of the Microbiology Commons
This Thesis is brought to you for free and open access by the Iowa State University Capstones, Theses and Dissertations at Iowa State University Digital
Repository. It has been accepted for inclusion in Retrospective Theses and Dissertations by an authorized administrator of Iowa State University Digital
Repository. For more information, please contact digirep@iastate.edu.
Recommended Citation
Victorsen, Alec DeMars Houlihan, "Identification and characterization of genes responsible for high persistence in Salmonella enterica
serovar Typhimurium" (2008). Retrospective Theses and Dissertations. 15439.
https://lib.dr.iastate.edu/rtd/15439
Identification and characterization of genes responsible for high persistence in 
Salmonella enterica serovar Typhimurium 
 
by 
 
 
Alec DeMars Houlihan Victorsen 
 
 
 
 
A thesis submitted to the graduate faculty 
 
in partial fulfillment of the requirements for the degree of 
 
MASTER OF SCIENCE 
 
 
 
Major:  Molecular, Cellular and Developmental Biology 
 
Program of Study Committee: 
Gregory J. Phillips, Major Professor 
Stephen H. Howell 
Kristen Johansen 
 
 
 
 
 
 
 
 
 
 
 
 
Iowa State University 
 
Ames, Iowa 
 
2008 
 
Copyright © Alec DeMars Houlihan Victorsen, 2008.  All rights reserved. 
1454607 
 
1454607 
 2008
ii 
 
 
Table of Contents 
GENERAL INTRODUCTION 1 
Introduction 1 
Objective of the study 2 
Thesis organization 2 
 
LITERATURE REVIEW 3 
Persistence 3 
Persistence in Escherichia coli 4 
Other TA Modules 6 
Toxins and persistence 10 
Other mechanisms of persistence 11 
hipQ 11 
Global regulators 11 
Persistence and metabolism 12 
Classes of high persistent mutants 11 
Persistence and biofilms 13 
Salmonella persistence 13 
 
A METHOD FOR MAPPING TRANSPOSON INSERTIONS BY RECOMBINEERING 15 
Abstract 15 
Introduction 15 
Materials and methods 17 
Bacterial strains and genetic manipulation 17 
Media 18 
Primers 18 
PCR templates 18 
Recombineering 19 
Genomic plasmids 19 
Sequencing data 20 
Results 20 
Mapping of Tn10 from the SGSC collection 20 
Mapping of new Tn10d mutants 21 
An improved PCR template for mapping Tn insertions 21 
Discussion 22 
Tables and figures 24 
 
IDENTITIFICATION AND CHARACTERIZATION OF GENES RESPONSIBLE FOR 
HIGH PERSISTENCE IN SALMONELLA ENTERICA SEROVAR TYPIMURIUM 28 
Abstract 28 
Background 28 
Materials and methods 32 
Media 32 
PCR primers 32 
iii 
 
 
Bacterial strains and plasmids 32 
Isolation of high persistence mutants 32 
High persistence assays 33 
MIC determination 34 
Assay for persistence to other antibiotics 34 
Growth rates of high persistent mutants 34 
Effect of growth phase on persistence 35 
Assaying delayed growth 35 
Isolation of Tn10d markers linked to high persistence 35 
Mapping Tn10d insertions by arbitrary PCR 36 
Recombineering 36 
P22 Transduction and linkage analysis 37 
Mapping Tn10d insertions by cloning 37 
Cloning and complementation 38 
shpAB regulation 38 
Results 39 
Isolation of high persistent mutants 39 
Growth rates 40 
Persistence to other antibiotics 40 
Role of relA in persistence 41 
Selectable markers linked to shp 41 
Linkage analyses of Tn10d insertions 42 
Mapping the high persistence locus of AS13 43 
Mapping the high persistence locus of AS17 and AS18 44 
Complementation of high persistence 44 
Expression of shpAB 45 
Predicted TA modules in Salmonella 46 
Discussion 46 
Tables and figures 55 
 
GENERAL CONCLUSION 70 
 
REFERENCES 76 
1 
 
 
GENERAL INTRODUCTION 
Introduction 
Persistence is the ability of a subpopulation of cells to survive exposure to antibiotics, 
and other stresses that reduce the viability of a bacterial culture.  Persistent cells have 
apparently entered into a distinct physiological state allowing them to survive environmental 
stresses.  Despite increased survivability, persisters are genetically identical to the rest of the 
population, as cultures grown from surviving cells remain as susceptible to antimicrobial 
stress as the original culture (5).  Although persistence has been observed for many decades, 
the phenomenon remains poorly understood, in part due to the relatively small number of 
persistent cells within a bacterial culture.  Persisters typically only comprise ~1×10-5 of the 
total population (62). 
Understanding the mechanisms of persistence is vital, as it could potentially reduce 
the efficacy of antibiotics and disinfectant treatments.  Furthermore, it may also contribute to 
the antibiotic tolerance of microbial biofilms.  It is well established that antibiotics kill 
planktonic cells more effectively than those within a biofilm in part due to the metabolically 
inactive state of cells within the biofilm (2, 80).  Furthermore, the ability of persisters to 
survive exposure to antibiotics may contribute to the development of true resistance since 
bacteria remaining viable for extended periods may mutate or acquire resistance via 
horizontal gene transfer.  The identification of genes responsible for persistence represents an 
important strategy to understand the genetic basis for the phenotype, as well as to potentially 
identify new targets for drug treatments to increase the efficacy of antibiotics. 
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Objective of the study 
The objective of this study was to identify and characterize genes responsible for 
increased persistence in the food borne pathogen Salmonella enterica serovar Typhimurium. 
 
Thesis organization 
This thesis contains two manuscripts that include the masters degree candidate, Alec 
Victorsen as first author.  Work by a previous student, including the isolation of high 
persistent strains and basic characterization of high persistence mutants, are also included 
and appropriately noted.  Both manuscripts are preceded by a literature review and conclude 
with a general conclusion. 
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LITERATURE REVIEW 
Persistence 
Joseph Bigger first described persistence in 1944 when he showed that cultures of 
Staphylococcus aureus consistently failed to be sterilized by penicillin.  Bigger hypothesized 
that the incomplete effectiveness of penicillin was due to a small number of cells within the 
population that have entered into an altered physiological state rendering them insensitive to 
the antibiotic.  Persistent cells were not truly antibiotic resistant however, since cultures 
grown from surviving cells remained as susceptible to penicillin as the original culture.  
Bigger hypothesized that surviving cells were dormant, non-dividing cells, a physiological 
state that he referred to as persistence (5). 
Since the first report by Bigger, persistence has been observed in multiple bacterial 
species, including Escherichia coli, Haemophilus influenzae, Pseudomonas aeruginosa, 
Salmonella enterica and Streptococcus pyogenes.  In addition, persistence has been observed 
in response to a variety of classes of antibiotics and other lethal stresses (5, 91). 
Persistence also explains the biphasic killing response typically observed when 
bacterial cultures are treated with antibiotics.  As shown in Figure 1, immediately following 
addition of an antibiotic, cell viability is reduced by several orders of magnitude.  However, 
after the initial killing phase, cell viability is not substantially reduced further due to the 
ability of persistent cells to survive antibiotic exposure.  Also shown in Figure 1 is the 
behavior of resistant mutants, which continue to grow in the presence of the antibiotic.  
Although not shown in Figure 1, removal of the antibiotic results in resumption of growth of 
the surviving persistent cells.   
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Figure 1.  Typical response of a bacterial culture to an antibiotic exposure.  See text for 
details.  Figure from (54). 
 
Persistence in Escherichia coli 
Despite the prevalence of persistence in the prokaryotic world, relatively little is 
known on the molecular mechanisms of phenomenon.  This limitation results in part, from 
the relative scarcity of persistent cells.  In Escherichia coli, for example, persistent cells 
typically comprise only between 10-5 or 10-6 of the total number of cells (62).  In order to 
better understand the genetic basis of persistence, Moyed and Bertrand isolated E. coli K-12 
mutants that showed in increase in the level of persistence (62).  To accomplish this, Moyed 
and Bertrand treated cultures with a chemical mutagen and subsequently exposed the cells to 
ampicillin for multiple rounds to enrich the culture for high persistence mutants. 
The resulting mutants were shown to exhibit ~100-fold increase in the level of 
persistence in response to β-lactam antibiotics.  In addition, the mutants also were shown to 
have increased tolerance to other stresses, such as elevated temperature, and starvation of 
thymine and diaminopimelic acid (62, 76, 94).  Subsequent mapping of the gene responsible 
for these phenotypes led to the identification of a two-gene operon named hipAB (high 
persistence).  Specifically, mutations in hipA lead to elevated persistence of E. coli.   
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Although the exact mechanism of how hipAB contributes to persistence remains 
unclear, subsequent work has led to a testable model.  The hipAB locus has been identified as 
a member of the toxin-antitoxin (TA) family of genes (7, 48).  TA modules were originally 
discovered as plasmid-encoded genes that ensure faithful distribution of plasmids to daughter 
cells, also known as post-segregational killing (67).  TA modules function by expressing two 
interactive polypeptides.  When in complex, the antitoxin prevents the toxin protein from 
inhibiting an essential cellular process, such as replication or translation.  When a plasmid-
less cell segregates in a population, the more stable toxin protein kills the cell because the 
less stable antitoxin is no longer being synthesized. 
Subsequent to their discovery on plasmids, TA modules were found encoded on the 
chromosome of several bacterial species (41).  For example, the mazEF locus encoded by the 
E. coli chromosome, was originally referred to as chpAB for chromosomal homologue of 
plasmid-encoded genes (59). 
Studies of hipAB reveal that hipA encodes a toxin, and hipB is an antitoxin that 
interacts directly with HipA.  Furthermore, in addition to controlling activity of the HipA 
toxin, the toxin/antitoxin complex also regulates transcription of hipAB (6).  Black et al. 
observed that HipB is capable of forming dimers that bind several sites within the hipAB 
operator.  HipB contains a helix-turn-helix motif allowing it to bind four operators with the 
sequence TATCCN8GGATA. 
In addition, the observation that hipA cannot be expressed in cells without hipB also 
being expressed is consistent with the theory that the hipAB locus as a TA module (6, 7).  
Additional studies showed that when HipA was synthesized at higher levels relative to HipB, 
the levels of persistence increased (48).  Collectively, these results suggest a model for how 
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hipAB functions in persistence.  When the balance of HipA becomes elevated with respect to 
HipB, the toxin inhibits cell growth by interaction with an as yet unknown cellular target.  
The signal causing lowering of levels of HipB in relation to HipA has also not been 
identified. 
Characterization of the hipA7 mutant has provided insights into how genetic 
alteration of the toxin gene leads to high persistence. The hipA7 allele contains two point 
mutations resulting in the amino acid substitutions G22S and D291A.  The first mutation 
renders hipA7 non-toxic, while the second mutation is necessary for increased persistence.  
The high persistence caused by these mutations represents a gain of function, as hipAB null 
mutants do not demonstrate high persistence (47).  However, hipA7 can be complemented by 
the wild-type hipA, indicating the gain of function is recessive (7, 63).  It has been proposed 
that the hipA7 gene product has lower affinity for HipB.  However, the significance of the 
G22S change is not clear. 
Biochemical studies indicated that HipA is a kinase capable of autophosphorylation, 
which is required for persistence (20).  Persister cells created by HipA are formed after the 
inoculation of cells from mid-log or stationary phase into fresh media (3, 29, 44).  
Furthermore, hipA7 mutants show an extended lag phase when introduction into fresh media 
(3).  
Other TA Modules 
Much like HipA, the toxins of other TA modules form complexes with their cognate 
antitoxins.  As summarized in Figure 2, the resulting complexes typically regulate the 
transcription of the TA module (7, 68).  The toxic effect of the toxin gene product is typically 
induced through proteolytic cleavage of the antitoxin, freeing the toxin from the TA-
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complexes and allowing it to bind its target (88, 89).  Concomitantly, with less antitoxin 
present, transcription of the operon results in synthesis of more antitoxin (70). 
Again like hipAB, most TA modules are structured as two-gene operons, with the 
second open reading frame encoding the toxin.  However, higBA and ygiUT are exceptions to 
this generalization; the toxin in these TA modules seems to be encoded by the first open 
reading frame (79, 86).  The open reading frames of TA modules also frequently overlap 
suggesting translational coupling of the toxin and antitoxin (69, 79). 
In the hok/sok module, which encodes a plasmid stabilization system, a small non-
coding RNA acts as an antitoxin (34).  This tripartite TA module includes a transmembrane 
toxin encoded by hok, whose translation is dependent on the product of mok (31).  The third 
gene, sok, encodes an antisense RNA that blocks translation of mok, therefore preventing 
translation of hok (85).  Similar to protein antitoxins, siRNA antitoxins are more prone to 
degradation and require constant transcription in order to control expression and activity of 
the toxin (33).  Although multiple TA modules that use small RNAs rather than a protein 
have been found, these still represent a small fraction of known TA modules. 
The targets of the TA toxins are typically essential for cell growth, including 
translation, transcription and DNA replication.  For example, mazEF, relBE, and higBA are 
all inhibitors of translation.  MazF halts translation by acting as a riboendonuclease, cleaving 
mRNA (18, 97).  RelE and HigB function in a similar manner to MazF, but rather than cleave 
free mRNA, the toxins digest mRNA within the ribosome (17, 19, 39, 71).  The TA modules 
ygiUT and parDE appear to act by inhibiting DNA replication.  YgiU is specifically tolerant 
towards fluoroquinolones, which interrupt DNA replication, suggesting YgiU targets DNA 
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gyrase or topoisomerase IV, whereas ParE has been observed to bind directly to DNA gyrase 
(42, 79) 
Some TA modules act as part of the stringent response in that they are activated by 
amino-acid starvation resulting in preferential stalling of translation of the antitoxin.  
Furthermore, mazEF transcription is directly regulated by ppGpp, a cell signaling molecule 
present during amino acid starvation (1).  Although direct regulation has not been observed, 
the production of persisters by hipA is also dependent on ppGpp (47).   
There are many theories that serve to explain why bacteria maintain multiple TA 
modules within their genomes.  Similar to their use on plasmids, they may be used to 
stabilize large portions of chromosomal DNA, such as super-integrons, integrons located 
within the chromosome that typically encode hundreds of genes, preventing them from being 
deleted (74, 84).  Another possibility is that chromosomal TA modules serve as “anti-
addiction” systems whereby a chromosomal TA module could allow bacteria to easily lose 
plasmids that are stabilized by a homologous TA module (75). 
However, the theory most relevant to persistence is that TA modules allow bacteria to 
adapt their growth to changing environments.  In fact, there seems to be a correlation 
between the number of TA modules within a bacterial genome and the diversity of 
environments in which those bacteria encounter.  For example obligate intracellular 
pathogens such as Chlamydia trachomatis are devoid of TA modules, while bacteria such as 
Vibrio cholerae, which inhabit both fresh and salt water environments, contain 
approximately 13 TA modules (69).  Whatever the function of TA modules, there must be a 
powerful selection to maintain a potentially lethal gene in the bacterial chromosome. 
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As a way to understand the function of TA modules, Tsilibaris et al. deleted all 
known TA modules in E. coli K-12 (87).  However, these cells did not show any phenotypic 
differences in comparison to wild-type cells.  This suggests that either the TA modules do not 
significantly contribute to survival under the laboratory conditions tested, or that there are 
unidentified TA modules that function in a similar manner to those that were deleted.  In fact, 
following the report by Tsilibaris et al. several additional TA modules have been found in E. 
coli, including yhaV/prlF, yeeUV, yafW/ykfI, and yfjZ/ypjF (10, 77).  The later three yeeUV, 
yafW/ykfI, and yfjZ/ypjF represent a new class of TA modules that were identified by 
searching for small open reading frames (10). 
In order to identify new TA modules, the RASTA-bacteria machine learning 
program, was created (78).  This program uses homology as well as searching for short 
tandem, overlapping open reading frames to identify potential TA modules.  Although this 
program represents a potentially useful way to identify new TA modules, putative genes will 
still need to be confirmed experimentally. 
 
Figure 2.  Autoregulation of the TA module relBE.  The RelBE complex can bind to the 
promoter, negatively regulating translation.  Degradation of RelB results in the increase in 
free RelE toxin that can globally inhibit translation (70). 
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Toxins and persistence  
To better understand how TA modules may contribute to persistence, Keren et al. 
used microarrays to investigate the changes in transcription in a hipA7 mutant.  They 
observed that many genes were significantly upregulated shortly after an antibiotic challenge.  
Interestingly, some of the genes represented other TA proteins, such as mazEF and relBE 
(44).  relBE is a TA module whose product cleaves mRNA within ribosomes resulting in a 
cessation of translation (71).  Keren et al. also observed that cells overexpressing RelE 
showed an increase in persistence in response to fluoroquinolones (44).  These results 
suggested that additional TA modules may also contribute to persistence.  As summarized in 
Figure 3, Lewis proposed a model where toxin proteins, which target fundamental cellular 
processes, such as DNA or RNA synthesis, serve to protect essential targets from corruption 
by antibiotics (53).  This inhibition is reversible; by increasing the levels of antitoxin protein, 
cells can reemerge from their persistent state at which point the antibiotic killing may resume 
(48, 70). 
Since persistent bacteria represent such a small number of cells within the culture, 
they are difficult to isolate in sufficient number to characterize.  In an attempt to isolate 
persister cells, Shah et al. used florescence-activated cell sorting to separate cells based on 
differential expression of green fluorescent protein (GFP).  After separation of populations of 
dormant and non-dormant cells, they used microarrays to identify differentially regulated 
genes in persistent cells.  Interestingly, the highest upregulated gene found was ygiU, part of 
a two-gene operon resembling the TA module higBA.  Shah et al. was unable to knockout the 
second gene in the operon, ygiT, suggesting it encodes the antitoxin of the module (79).  It 
was proposed that the target of the toxin may be DNA gyrase or topoisomerase IV, which are 
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the affected by fluoroquinolones, as overexpression of ygiU increased persistence against 
ofloxacin and cefotaxime.  Although ygiUT may be a TA module, ygiU has been reported to 
be a global regulator that regulates the two-component regulatory system qseBC that is 
necessary for biofilm formation (35). 
 
Figure 3.  Proposed mode of action of toxin/antitoxins on antibiotic activity.  Whereas an 
antibiotic (circle) will bind to its target causing cell death by corrupting the target, in 
persisters the antibiotic still binds the antibiotic, yet does not result in a corrupted target (53). 
 
Other mechanisms of persistence 
hipQ.  A second locus resulting in high persistence was found by Wolfson et al. that 
was increased persistence in E. coli in response to quinolones and as β-lactam antibiotics 
(94).  The gene responsible for this trait was designated hipQ and maps to approximately 0.7 
min downstream from the leu operon.  However, the gene remains unidentified and 
uncharacterized. 
Global regulators.  Strains of E. coli with altered levels of persistence have also been 
found that result from mutations in genes other than TA modules.  Li and Zhang observed 
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that when phoU was interrupted by a transposon the level of persistence drastically decreased 
(56).  The authors proposed that in addition to being a negative regulator of the phosphate 
regulon, including the phosphate-induced two-component system phoBR, PhoU is actually a 
global negative regulator.  Although phoU can apparently alter the levels of persistence, the 
relevant genes regulated by PhoU have not been discovered. 
Persistence and metabolism.  A study by Spoering et al. described additional two 
genes, glpD and plsB that can alter persistence in E. coli (83).  GlpD converts glycerol-3-
phosphate (G3P) into dihydroxyacetone phosphate under aerobic conditions and may 
participate in formation of persisters during stationary phase.  Over expression of GlpD 
increases the intercellular levels of G3P, which in turn negatively regulates the levels of the 
glp regulon via the repressor glpR.  Although deletions in glpD and glpR could increase the 
levels of persistence independently, the increase was greatest when the G3P concentration 
increased from the loss of glpD, in addition to a loss of glpR suppressing the glp regulon. 
PlsB uses G3P in the biosynthesis of phospholipids.  The authors argue that the G3P 
concentration can determine the number of persisters that are formed.  Interrupting these 
processes regulated by G3P would induce a state dormancy either as a result of a lack of 
phospholipids, or by the repression of glpR. 
Expression of proteins that are toxic when ectopically overexpressed has also been 
observed to affect persistence when expressed at sub-lethal levels.  This further supports the 
theory that the inhibition a cellular process is the cause persistence (90). 
Classes of high persistent mutants 
Careful examination of growth kinetics of persistent cells using single-cell 
microscopy revealed high persistent mutants can be organized into two classes.  Type-I 
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persisters, including hipA mutants, must reach stationary phase before being inoculated into 
fresh media for persisters to develop (3, 43). 
Type-II persisters, on the other hand, including hipQ mutants, form persister cells 
during exponential phase rather than during stationary phase.  This class of persisters, rather 
than stay completely dormant, continue to divide at a much slower rate than the remaining 
cells in the population (3). 
Persistence and biofilms 
Most bacteria, including E. coli and S. enterica are able to form biofilms, a solid 
exopolysaccharide matrix created by a bacterial population to adhere to a solid surface (37).  
This matrix is able to protect the biofilm from the host’s immune cells, as well as some 
antimicrobial agents (51, 92).  While protracted diffusion through the matrix protects against 
aminoglycosides, fluoroquinolones antibiotics are still able to freely diffuse (2, 80). 
The protective nature of the matrix decreases the efficacy of antibiotics to treat 
persistent biofilm infections.  Persisters surviving antibiotic exposure, which would normally 
be killed by the immune system, are protected within the biofilm.  It has been proposed that 
repopulation of biofilm infections from persister cells leads to chronic infection, but may also 
allow the cells to acquire true resistance further hindering treatment. 
For these reasons, understanding the molecular mechanisms of persistence is relevant 
and may yield new potential targets for the treatment of biofilms that may synergistically 
create better treatments of biofilm infections (54). 
Salmonella persistence 
Salmonella is an important pathogen of humans and animals.  It is the causative agent 
of a common form of food-borne illness and causes significant economic impact each year in 
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the United States.  Approximately 45% of S. enterica serovar Typhimurium isolates also now 
demonstrate multi-drug resistance with outbreaks of these strains occurring frequently (12-
16). 
While Salmonella is able to survive antimicrobial exposure, the mechanisms of 
persistence in this pathogen are also not known.  Although Salmonella encodes multiple TA 
modules (Table 1), it does not contain homologues of hipAB or mazEF.  It does however, 
contain homologues of phoU and glpD (69).  However, the contribution of any of these genes 
to persistence in Salmonella remains unknown. 
Homologous 
TA module Salmonella genes 
relBE STM1551/STM1550 
relBE STM3517/STM3516 
relBE STM4449/STM4450 
parDE STM2955.S/STM2954.2N 
higBA STM3907/STM3906 
higBA STM4033/STM4032.2N 
vapBC STM3034/STM3033 
phd/doc yhhV/STM3558 
Table 1.  Salmonella Typhimurium genes homologous to known TA modules (69). 
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A METHOD FOR MAPPING TRANSPOSON INSERTIONS BY 
RECOMBINEERING 
 
A paper to be submitted to the journal of Biotechniques 
 
Alec Victorsen and Gregory J. Phillips 
 
ABSTRACT 
Transposable elements have been utilized for many years as genetic tools to study a 
wide variety of cellular processes in bacteria.  Several molecular techniques have been 
developed to determine the site of transposon insertion within the bacterial chromosome.  
Transposons that contain a conditional origin of replication, so called plasposons, have 
recently become popular as they provide a convenient and effective method to clone and map 
transposon insertion sites.  Plasposons, however, cannot be used to map the insertion sites of 
transposons that do not contain an origin of replication, such as those created with derivatives 
of Tn10.  We have developed a way to convert a transposon into a plasposon by using 
homologous recombination to introduce a conditional origin of replication from the plasmid 
R6K.  Using this technique we have mapped insertions sites of Tn10 and Tn10d in several 
strains of Salmonella enterica serovar Typhimurium. 
INTRODUCTION 
Transposons have proven to be an invaluable tool to study gene function in bacteria 
(45).  The transposon Tn10, initially identified in 1975, as well as Tn5 have been modified 
numerous times to create a large variety of useful genetic elements (46, 93).  For example, a 
common derivative is the mini-Tn10 derivative, Tn10d, which lacks the transposase gene, 
stabilizing the element in the chromosome (93).  The precise point of insertion of Tn10d, as 
well as other Tn10 and Tn5 derivatives, is now routinely determined by DNA sequencing.  
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Several methods, including direct sequencing of genomic DNA and arbitrary PCR are 
commonly used (52).  However, these methods can be tedious, and require the optimization 
of reaction conditions.  Alternatively, the Tn element identified via southern blot, can be 
cloned into a plasmid vector directly from the chromosome and the site of insertion 
determined by DNA sequencing. 
In order to make cloning the site of Tn insertion more convenient, new elements that 
incorporate a conditional origin of replication (ori) within the Tn element have been 
developed.  These elements, referred to as plasposons, are converted to self-replicating 
plasmids by isolating genomic DNA, digesting the DNA with appropriate restriction 
enzymes and religating the products (26, 73).  The ligation products are then transformed into 
a strain of E. coli that supports replication of the plasmid origin. 
Plasposons typically utilize the R6Kγ ori and used in combination with E. coli hosts 
that express the trans-acting replication protein π.  The pir gene, encoding π, has been 
incorporated into the chromosome of multiple E. coli strains, including strains that are 
commercially available.  The R6Kγ ori does not initiate replication when introduced to cells 
that do not express π; rather, in these cases, it represents an inert sequence of DNA.  
However, upon transformation into a pir+ host, it supports replication of extra-chromosomal 
elements.  Multiple plasmids have been developed that contain R6Kγ-ori along with 
selectable markers such as kanamycin resistance (24, 50). 
Recombineering is a novel tool utilizing the mechanism of homologous 
recombination of bacteriophage λ to alter plasmid and chromosomal DNA sequences in 
bacteria (24, 96).  Several systems have been developed in which the products of the λ 
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recombination system, including the genes: exo, beta, and gam, are expressed from 
temperature sensitive plasmids (25). 
When cells expressing the Red proteins are transformed with linear DNA containing 
as little as 45-bp of homology to the host’s DNA, the Red proteins promote efficient 
integration of the DNA at the region of homology.  Since such a sort homologous sequence is 
required for recombination, PCR can be used to generate the linear DNA for transformation.  
The primers used to create the linear DNA are hybrid primers, containing as few as 45-bp of 
sequence homologous to the target, as well as sequences that anneal to the sequence being 
inserted.  Typically the template for these PCR reactions includes an antibiotic resistance 
marker to directly select for recombinants. 
We take advantage of the known DNA sequences of Tn10 and Tn10d to introduce an 
R6Kγ ori and kanamycin resistance (KanR) cassette into the tetAR genes carried by the Tn 
elements.  This strategy has allowed us to map the site of insertion of several S. enterica 
mutants that were previously generated with Tn10 or Tn10d.  This method should also be a 
useful strategy to map the insertion sites in collections of mutants generated by other Tn 
elements. 
MATERIALS AND METHODS 
Bacterial strains and genetic manipulation.  TT169, TT173, TT215 and TT744 
were obtained from the Salmonella Genetic Stock Center (SGSC).  New Tn10d mutant 
insertions were generated by transforming Salmonella enterica LT2 derived strains with 
pNK972, a temperature sensitive plasmid expressing the Tn10 transposase (93).  P22 phage 
lysates were prepared from AS30 containing Tn10d and used to transduce the Tn element 
into the pNK972 transformants to create random insertions.  Transductants were grown at 
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42°C overnight and screened for their inability to grow on minimal media by patching 
individual colonies onto minimal M9 glucose plates.  The pir+ host for recovery of R6Kγ ori 
plasmids was EC100D (Epicentre, Madison WI). 
Media.  All strains were grown on LB agar plates or in LB broth unless otherwise 
noted (60).  Antibiotics were used at the following concentrations: kanamycin (30 µg/ml), 
tetracycline (20 µg/ml), ampicillin (100 µg/ml). Minimal M9 media was supplemented with 
amino acids, phenylalanine and threonine, at a concentration of 0.3 mM. 
Primers.  The PCR primers used for recombineering are shown in Table 1.1.  In 
general, they contained ~45 bases homologous to the tetAR genes of Tn10 along with regions 
that anneal to the template (underlined sequence).  In addition to these two regions, the 
pRL27 primers contain additional bases creating BamHI or EcoRI restriction sites. 
PCR templates.  Templates for PCR included pRL27 (50) or pPL1 (Figure 1.1) and 
included a KanR cassette and the R6Kγ ori.  The pPL1 plasmid is a derivative of pRL27 and 
was constructed by PCR amplification of pRL27 using the NheI-pRL27 primers (Table 1.1).  
The 2.77-kbp product was digested with NheI and religated.  After recovering the circular 
plasmid from EC100D, the plasmid was further modified by replacing the ~350-bp PflMI 
and SmaI segment from within the KanR gene with a DNA fragment synthesized without 
recognition sites for the restriction enzymes BsaWI or BsrFI (Integrated DNA Technologies, 
Coralville IA). 
In order to maximize the amount of PCR product that was recovered, an initial PCR 
reaction was gel purified to remove the template.  This PCR fragment was in turn used as a 
template for a second, scaled up round of PCR.  The products were pooled and purified using 
the Qiagen PCR purification kit (Qiagen, Valencia CA). 
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Recombineering.  Strains were recombineered using the Quick and Easy E. coli 
Gene Deletion Kit Genome Engineering by Red®/ET® Recombination (Gene Bridges, 
Dresden Germany).  Approximately 1000 ng of PCR product was used per reaction.  
Electrocompetent cells were prepared by diluting overnight cultures 1:50 and growing to an 
OD600 of 0.6.  1.4 ml of cells were washed three times with 1 ml of MOPS solution (1 mM 
MOPS in 20% glycerol) and resuspended in 20 µl MOPS solution.  Recombinants were 
selected for resistance to KanR and screened for their loss of resistance to tetracycline (TetS) 
(Figure 1.2). 
Genomic plasmids.  Genomic DNA was isolated using the MasterPure Complete 
DNA and RNA Isolation kit (Epicentre, Madison WI) from four KanR, TetS recombinants.  
When digesting with BamHI, EcoRI, 4 µg of DNA was digested in 20 µL reactions.  The 
digestions were incubated at 37°C overnight.  EcoRI reactions were heat inactivated at 65°C 
for 20 minutes. The BamHI reaction was purified using the Qiagen Qiaex II kit because it 
could not be heat inactivated.  Each digestion was then directly used in a 50 µl ligation 
reaction incubated at 14°C overnight.  The ligations were incubated at 65°C for 10 minutes 
and either used to transform 100 µL chemically competent EC100D, or purified and 
electroporated into electrocompetent EC100D.  The entire culture was plated on LB plates 
with the appropriate antibiotics. 
When genomic DNA was digested with HaeII, BsrFI and BsaWI this same method 
was used.  However due to the fact that these enzymes cut more frequently, they yield more 
fragments.  In order to remove many of the fragments shorter than 1-kbp, the digestions were 
purified with the NucleoSpin Extract II kit (Macherey-Nagel, Bethlehem, PA) using a 1:10 
dilution of NT buffer. 
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Sequencing data.  The Tn10R primer was used to sequence plasmids generated by 
digestion with BamHI and HaeII.  The Tn elements contain restriction sites for both these 
enzymes between the Tn10L priming site and tetA, therefore Tn10L could not be used 
(Figure 1.2).  For this same reason, Tn10L primer was used when sequencing, plasmids 
generated by EcoRI digestion.  It is also noted that when reporting the site of insertion, 9-bp 
duplications are generated during the transposon reaction (38). 
RESULTS 
Mapping of Tn10 from the SGSC collection.  In order to confirm the veracity of 
this method, we mapped the locations of Tn10 in two auxotrophs obtained from SGSC.  The 
Tn10 elements within TT173 and TT744 had been previously genetically mapped to cysC 
and argA respectively (Table 1.3).  However, the exact site of insertion was not known.  The 
tetAR genes within the Tn elements were replaced with a DNA fragment containing KanR 
and R6Kγ ori generated from pRL27.  One of the limitations to Tn insertion site mapping 
using the strategy described here is that digestion with 6-bp cutting restriction enzyme often 
yields large plasmids that transform relatively inefficiently.  To reduce the size of the 
plasmids, we incorporated sequences encoding restriction enzymes recognition sites for 
BamHI or EcoRI into the PCR primers (Table 1.1).  After digestion the genomic DNA with 
either of these two enzymes, plasmids were recovered from EC100D and sequenced using 
the Tn10L primer (Table 1.4).  Using this approach, the Tn10 insertions in TT173 and TT744 
were found to be in cysN and argA respectively.  Due to the higher resolution of this new 
mapping technique, we found the Tn10 in TT173 to be in cysN, which is immediately 
upstream from cysC that was the insertion site that was originally reported. 
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Mapping of new Tn10d mutants.  We also generated new Tn insertions mutants of 
S. Typhimurium using Tn10d as described in Materials and Methods.  The mutagenized cells 
were screened to identify auxotrophs.  Several auxotrophs that failed to grow on minimal 
media were identified, and AV22 and AV23 were selected for mapping.  Also, AV24 was 
selected because of its poor growth on minimal medium. 
After recombineering with the PCR products generated from pRL27 as described, 
plasmids were isolated following digestion of with EcoRI or BamHI.  Sequencing the EcoRI-
generated plasmids with the Tn10d-L primer and the BamHI with the Tn10d-R primer 
showed the insertions in the auxotrophs AV22 and AV23 were in pheA, and the promoter 
region of thr respectively (Table 1.4).  The mutant AV24 was a result of an insertion in yegS, 
identified as a lipid kinase (65).  This proved to be an interesting mutation due to its 
phenotypic growth displayed on minimal plates.  Although yegS is not an essential gene, it is 
clearly required for normal growth. 
To confirm the identity of the genes disrupted in AV23 and AV22, the mutants were 
grown on minimal media and minimal media supplemented with the phenylalanine or 
threonine.  Each strain grew on the appropriately supplemented plates as predicted. 
An improved PCR template for mapping Tn insertions.  Despite engineering 
restriction sites (EcoRI and BamHI) into the PCR products, several of the plasmids we 
isolated were still relatively large, (greater than 5-kbp), and low number of transformants 
were occasionally obtained.  By further reducing the size of the resulting plasmids, we 
predicted that we would continue to improve the efficiency of this mapping technique. 
Consequently, we used restriction enzymes that recognize 5-bp recognition sites, 
which cut genomic DNA more frequently.  To implement this strategy, we first identified 5-
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bp cutting enzymes that do not cut within Tn10, and that also consistently generate 
compatible 5’ or 3’-prime overhangs.  Although BsaWI (WCCGGW) and BsrFI (RCCGGY) 
fulfill these requirements, they are found within the kan gene of pRL27.   
In order to use these enzymes for mapping, we constructed a new plasmid pPL1 
(Figure 1.1) that resulted in a PCR product that was devoid of BsaWI and BsrFI restriction 
sites.  Use of this plasmid as PCR template was used to map the location of Tn10 in the 
auxotrophs TT169 and TT215.  As shown in Table 1.5, Tn10 was inserted into serA, and lysA 
respectively; the same locations as reported by the SGSC. 
A third enzyme HaeII (RGCGCY) was also used in these studies to map and confirm 
the insertions of Tn10d in AV25, AV26, and AV27, the recombineered strains that had been 
mapped with BamHI and EcoRI.  Utilizing this enzyme showed no difference in the location 
of the Tn elements, yet it proved to be more efficient in yielding self-ligated products.  
However, HaeII cannot be used to map the insertion site of Tn10, since there are multiple 
sites within the element. 
During the mapping of the Tn site insertions, we frequently obtained multiple 
insertions into the plasmids that did not represent contiguous regions of the chromosome.  
While these insertions did not interfere with identification of the Tn insertion site (Table 1.5), 
they did enlarge the plasmid sizes.  To improve the efficiency of recovering plasmids without 
multiple inserts, we routinely purified the chromosomal digestions to remove small digestion 
products prior to ligation. 
DISCUSSION 
We have taken advantage of recombineering technology to map the site of transposon 
insertions in bacterial genomes.  In addition to the strategy of incorporating a selectable KanR 
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marker and the R6Kγ ori into Tn10 and Tn10d elements, we also constructed a new plasmid 
to serve as a PCR template for recombineering.  Our attempts at mapping Tn insertion sites 
by recombineering included adding unique restriction sites, (BamHI or EcoRI) within the 
PCR product in order to reduce the size of the recovered plasmids.  While this strategy was 
used to map insertions, the resulting plasmids remained relatively large, making their 
recovery inefficient.  Additionally, while DNA sequencing the plasmids revealed the junction 
between the Tn element and the chromosomal DNA, non-contiguous inserts joined at 
restriction sites were common in the plasmids, further increasing plasmid size.  In addition to 
the insertion of additional DNA fragments during the ligation reaction, illegitimate 
recombination within the plasmids was another likely source of sequence variability within 
the plasmids.  This phenomenon has been observed previously (26).  Since we propagated the 
plasmids in strains where copy numbers would be high, overproduction of gene products 
could be detrimental to cell growth.  This metabolic burden could be relieved by 
recombination resulting in deletions of portions of the plasmid. 
Use of a modified plasmid for PCR that is devoid of restriction enzyme sites that 
recognize 5-bp recognition sites further improved the mapping strategy.  Restriction enzymes 
HaeII, BsaWI and BsrFI sites, which cut the Salmonella chromosome on average of every 
1024 bases, but do not cut within Tn10 (with the exception of HaeII) or Tn10d yielded 
smaller plasmids that were more efficiently recovered by transformation.  As a consequence, 
use of these enzymes has proven to be the most efficient in the creation of plasmids from 
genomic DNA. 
We have used the recombineering method to successfully map the locations of eight 
Salmonella strains containing Tn10 or Tn10d.  With properly designed PCR primers, this 
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method can be used to map other Tn elements in any bacterial species in which 
recombineering is feasible. 
 
TABLES AND FIGURES 
 
 
Figure 1.1. pPL1 plasmid.  Shown are the locations of the sense (S) and antisense (AS) 
priming sites for recombineering PCR products, origin of transfer (oriT), R6Kγ origin of 
replication (R6K ori), and kan (KanR). 
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Figure 1.2.  Recombination of PCR products into Tn10 and Tn10d.  Tn10 (top) and 
Tn10d (bottom) elements showing the locations of EcoRI, BamHI, HaeII, BsaWI, and BsrFI 
restriction sites.  pRL27 PCR fragment (middle) contains regions (grey) homologous to Tn10 
and Tn10d.  Sequencing primer sites are shown in white. 
 
Primer Sequence 
Tn10-BamHI-pRL27.S 5'-AGACCCACTTTCACATTTAAGTTGTTTTTCTAATCCGCATATGATCAAGGATCCCGTTAAGTGTTCCTGTGTCACTC-3' 
Tn10-EcoRI-pRL27.AS 5'-AGCACTTGTCTCCTGTTTACTCCCCTGAGCTTGAGGGGTTAACATGAATTCGTGATCTGATCCTTCAACTCAGC-3' 
Tn10-pPL1.S 5'-CCCACTTTCACATTTAAGTTGTTTTTCTAATCCGCATATGATCAACCGTTAAGTGTTCCTGTGTCACTC-3' 
Tn10-pPL1.AS 5'-AGCACTTGTCTCCTGTTTACTCCCCTGAGCTTGAGGGGTTAACATGAACGTGATCTGATCCTTCAACTCAGC-3' 
Tn10d-L 5'-ATGGAAACGGCGTTCACTCCAATC-3' 
Tn10d-R 5'-ACCAACCATTTGTTAAATCAGTTTTTGTTGTGA-3' 
Tn10-L 5'-GCCAACGTTAAGCTGTTGAGTCGT-3' 
NheI-pRL27.S 5'-AGCTAGCTTACATGGCGATAGCTAGACTGG-3' 
NheI-pRL27.AS 5'-AGCTAGCGAACGCGCGGATTCTTTATCACTGATAAGTTGGTGGA-3' 
Table 1.1.  PCR and sequencing primers used in this study.  The underlined sequences 
represent regions homologous to pRL27 or pPL1.  The sequences in bold were added to 
introduce restriction sites within the primer. 
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Strain Description 
Recombineering 
Template Source 
TT173 cysC1511::Tn10  SGSC 
TT744 argA1832::Tn10 his-863  SGSC 
TT215 lysA565::Tn10  SGSC 
TT169 serA977::Tn10  SGSC 
AS30 zxx::Tn10d  this paper 
AV5 TT173 tetA::kan(pRL27) pRL27 this paper 
AV4 TT744 tetA::kan pRL27 this paper 
AV33 TT215 tetA::kan pPL1 this paper 
AV32 TT169 tetA::kan pPL1 this paper 
AV22 zaa::Tn10d  this paper 
AV23 pheA::Tn10d  this paper 
AV24 yegS::Tn10d  this paper 
AV25 AV23 tetA::kan pRL27 this paper 
AV26 AV24 tetA::kan pRL27 this paper 
AV27 AV22 tetA::kan pRL27 this paper 
Table 1.2. Bacterial strains used in this study. 
 
Strain 
Previously 
Reported Gene Mapped gene Position 
TT173 cysC cysN 3074124 
TT744 argA argA 3143900 
TT215 lysA lysA 3173089 
TT169 serA serA 3223934 
AV24 - yegS 2234798 
AV23 - pheA 2808511 
AV22 - thrL promoter 187 
Table 1.3.  Tn10 and Tn10d mutants mapped in this study. 
 
Strain Primer Sequence 
AV5 Tn10L AATGATTTTTACCAAAATCATTAGGGGATTCATCAGGGCCGAGCGTGAGCAGGGCATTACTATTGACGTCGCGTACCGCTATTTCTCCACGGAAAGACGAAAATTTATTAT 
AV4 Tn10L AATGATTTTTACCAAAATCATTAGGGGATTCATCAGGGCGCTGTATCCTTTTGTGGAAGAGAAAATAGGCGAAATGGCCTGCGTAGCGGTACATCCGGATTACCGCAGCTC 
AV27 Tn10d-R TAACTTAATGATTTTTACCAAAATCATTAGGGGATTCATCAGTGCACCGCATGAAATCACGTTTAATCTGGATGGCGAACCACTCAGCGGGCAAGAATTTCATATTGAGGT 
AV25 Tn10d-L TAACTTAATGATTTTGATAAAAATCATTAGGGGATTCATCAGCACGGAGTCTTCAATGATAAGCTGGAACAGACGGGTAATGTAGTGTGCGTCGAGATGGTGGGCTTTACC 
AV26 Tn10d-L TAACTTAATGATTTTGATAAAAATCATTAGGGGATTCATCAGTGTTGTGTACTCTGTCATTTTTATTTGTCTGTCTTGTATTCCTATATTGGTTAAAGTATCTGCCCGCCT 
Table 1.4.  Sequence data from plasmids generated by digestion with BamHI and 
EcoRI.  The underlined sequences represent Tn10 or Tn10d. 
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Strain Primer Sequence 
AV33 Tn10L AATGATTTTTACCAAAATCATTAGGGGATTCATCAGTGGGAAGCCGCCATTTCGTGCTGGTCGACGCTGGTTTTAACGATCTGATGCGCCCGGCGATGTACGGTAGCTATC 
AV32 Tn10L AATGATTTTTACCAAAATCATTAGGGGATTCATCAGTGCTGCACCTGAGTTGCATTACCGAGCGGCAGTTTATTTTCAATATCATAGAAATAGACATGCATCCCCAGCGaA 
AV27 Tn10d-L TAACTTAATGATTTTGATAAAAATCATTAGGGGATTCATCAGTGCGGTGCATGAATATCAAACCACGCTGAGGCGCCCCCACAGCGTTGCATCGCGTCCAATTTCAATAAA 
AV25 Tn10d-L TAACTTAATGATTTTGATAAAAATCATTAGGGGATTCATCAGCACGGAGTCTTCAATGATAAGCTGGAACAGACGGGTAATGTAGTGTGCGTCGAGATGGTGGGCTTTACC 
AV26 Tn10d-L TAACTTAATGATTTTGATAAAAATCATTAGGGGATTCATCAGTGTTGTGTACTCTGTCATTTTTATTTGTCTGTCTTGTATTCCTATATTGGTTAAAGTATCTGCCCGCCT 
Table 1.5. Sequence data from plasmids generated by digestion with HaeII, BsaWI, and 
BsrFI.  Underlined sequences represent portions of the Tn10d transposon.  The GGCGCC of 
AV24, shown in bold, represents a HaeII site, after which a sequence representing another 
region of the genome occurred. 
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RESPONSIBLE FOR HIGH PERSISTENCE IN SALMONELLA 
ENTERICA SEROVAR TYPIMURIUM 
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Alec Victorsen, Andrew Slattery* and Gregory J. Phillips 
 
ABSTRACT 
The ability of bacteria to survive lethal challenges of antibiotics, and other 
environmental stresses, is known as persistence.  To better understand the genetic basis of 
persistence, we have isolated new mutants of Salmonella enterica serovar Typhimurium that 
show an increased level of persistence to antibiotic exposure.  Two loci were mapped and 
characterized.  One first includes two previously uncharacterized genes (STM4528 and 
STM4529) that were renamed shpAB for Salmonella high persistence.  The second locus was 
mapped to metG, which encodes a methionyl-tRNA synthetase.  Genetic analysis of the 
shpAB locus using deletion mutants, gene expression studies, as well as characterization of 
promoter activity and by lacZ gene fusions reveal that these genes appear to encode a 
toxin/antitoxin (TA) module.  Similar to studies in Escherichia coli K-12, changes in the 
expression or activity of TA modules components can also lead to high persistence in S. 
enterica. 
BACKGROUND 
The phenomenon of antimicrobial persistence was originally characterized in 
Staphlococcus by J. Bigger (5).  Cultures treated with penicillin were rarely sterilized, 
apparently the result of a relatively small subpopulation of cells that survived antibiotic 
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exposure.  These cells were distinct from antibiotic resistant mutants and were referred to as 
persisters.  They appeared to represent cells that had entered a state of dormancy, 
altruistically forgoing division in order to increase the survival of the population to lethal 
conditions.  While persistence has been observed for decades, relatively little is known about 
the molecular mechanisms of this trait (53, 54). 
Persistence has been documented in both Gram-positive bacteria such as 
Staphylococcus pyogenes, Streptococcus pneumoniae and Staphylococcus aureus, as well as 
Gram-negative species including E. coli, Salmonella enterica, Pseudomonas aeruginosa and 
Haemophilus influenza (5, 91).  In all cases, persisters are genetically identical to non-
persister cells (3).  Cultures grown from enriched populations of persistent cells remain as 
susceptible to antibiotics as cells in the original culture (5).  The paucity of persister cells 
within a bacterial culture has hindered elucidating the mechanisms of persistence on a 
genetic and molecular level. 
The first successful attempt to understand persistence required the isolation of E. coli 
K-12 mutants that showed elevated levels of antibiotic tolerance.  By enriching for mutants 
that survived exposure to ampicillin, Moyed and Bertrand identified the hipAB high 
persistence locus.  Specific mutations in hipA resulted in a 100-1000-fold increase in survival 
to exposure to antibiotics (62, 94).  Furthermore, these mutants showed an enhanced survival 
to other lethal conditions, such as elevated temperature, thymine and diaminopimelic acid 
starvation (76).  More recent studies have carefully examined the hipA mutants using novel 
techniques to monitor the growth of single cells.  These studies have revealed that hipA 
mutants have an extended lag phase when inoculated into fresh media and that persister cells 
formed by hipA arise upon exit from stationary phase (29). 
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Characterization of hipA revealed that it encodes the toxic component of a toxin-
antitoxin (TA) module.  Typically, multiple TA modules are found on the chromosome of 
bacteria, as well as on plasmids where their function is to ensure stable inheritance of extra-
chromosomal elements (32, 72).  The toxic effects of HipA can be inhibited through direct 
interaction with the antitoxin HipB, which also serves as a negative regulator or the hipAB 
promoter (6, 7).  The exact target of the HipA toxin remains unknown. 
Since the discovery of hipAB, it has also been shown that other TA modules such as 
mazEF, relBE and ygiUT can increase persistence when the levels of toxin relative to 
antitoxin are altered as a result of expressing the toxin on an inducible plasmid (44, 79, 90).  
These toxins are known to inhibit essential processes such as translation and transcription 
(17-19, 39, 42, 71, 79, 97).  Therefore, it has been proposed that persistence is a result of the 
regulated inhibition of macromolecular synthesis (44, 79).  By this model, inhibition of 
essential cellular processes such as protein synthesis or DNA replication enable a cell to 
induce a state of dormancy, protecting them from conditions that would typically kill actively 
growing cells such as antibiotics.  Even expression of non-TA proteins, which are toxic when 
overexpressed, can also induce persistence when expressed at sub-lethal levels(90). 
Continued characterization of persistence in E. coli has revealed that genes involved 
in other cellular processes can also lead to elevated persistence.  For example, mutations in 
glpD and plsB can increase the level of persistence.  PlsB appears to achieve this increase by 
slowing phospholipid synthesis causing cell division to stall thus achieving a state of 
dormancy.  While glpD seems to function indirectly by increasing the intracellular levels of 
glycerol-3-phosphate resulting in a decrease in expression of genes in the glp regulon (83). 
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Another gene that is involved in persistence is the transcriptional repressor encoded 
by phoU.  E. coli strains containing a transposon insertion interrupting phoU show a decrease 
in persistence (56).  It has been proposed that in addition to being a negative regulator of the 
Pho regulon, PhoU is a global negative regulator of gene expression.  However, the genes 
regulated by PhoU that cause high persistence are still unknown. 
Understanding the cellular mechanisms leading to persistence is important as any 
process that reduces the effectiveness of antibiotics or antimicrobials could potentially have 
consequences to human and animal health.  For example, persistence is thought to contribute 
to the antibiotic tolerance of biofilms (55).  It is known that cells within a biofilm are more 
tolerant of antibiotics than those growing planktonically.  Understanding the process whereby 
cells enter a state of persistence could lead to new treatments increasing the effectiveness of 
antimicrobials.  Furthermore, persistence could potentially contribute to resistance by 
allowing surviving cells to gain resistance by mutation or horizontal gene transfer (82). 
A vast majority of research on persistence has been conducted using E. coli K-12.  In 
order to better understand persistence in other human pathogens, we chose to characterize 
Salmonella enterica serovar Typhimurium.  Approximately 45% of S. enterica serovar 
Typhimurium isolates demonstrate multi-drug resistance, with outbreaks of these strains 
occurring frequently (12-16).  Despite the similarity between Salmonella enterica and E. coli, 
inspection of the Salmonella enterica (strain LT2) genomic DNA sequence reveals no 
homologues of hipAB even though our studies indicate that is capable of entering into a state 
of persistence.  Therefore, to identify the mechanisms of persistence in this pathogen, we 
have isolated several mutants that show elevated levels of persistence.  This report describes 
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the mapping and preliminary characterization of two loci responsible for high persistence, 
metG and shpAB. 
MATERIALS AND METHODS 
Media.  All bacteria were grown on LB agar plates or in LB broth unless otherwise 
noted (60).  LBEDO broth is LB broth containing 1 M D-Glucose and 1x E Salts and was 
used for bacteriophage P22 transduction experiments (57).  Antibiotics were purchased from 
Sigma Chemical Co., St. Louis, Mo. and were used at the following concentrations: 
kanamycin (50 µg/ml), tetracycline (20 µg/ml), ampicillin (100 µg/ml), ofloxacin (5 µg/ml), 
piperacillin (200 µg/ml), or chloramphenicol (20 µg/ml).  EGTA was used at a concentration 
of 10mM.  The penicillinase stock was made at 2500 U/ml in 50mM Tris-HCl pH 7.5, 50mM 
NaCl, 1mM EDTA, 1mM dithiothreitol (DTT), in 20% glycerol.  100 µl of penicillinase 
stock were diluted in 4.9 ml LB to create the working solution. 
PCR primers.  Primers used in this study are found in Table 2.1. 
Bacterial strains and plasmids.  Bacterial strains are listed in Table 2.2.  DH5α was 
used for all cloning with the exception of cloning shpA, which required EPI400 (Epicentre, 
Madison WI) to be used.  TransforMax™ EC100D™ pir+ electrocompetent E. coli cells 
(Epicentre, Madison WI) was used for selection of transformants with R6K origin of 
replication (ori). 
Isolation of high persistence mutants.  Salmonella enterica serovar Typhimurium 
strain LT2 was mutagenized with N-methyl-N-nitro-N-nitrosoguanidine (MNNG).  Cells 
were grown to a concentration of 108 CFU/ml and exposed to 50 µg/ml of MNNG for 10 
min.  Cells were then washed twice with 8.5% NaCl and resuspended to a concentration of 
109 CFU/ml and incubated overnight. 
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High persistence mutants were screened by inoculating 40 ml of LB in a 250 ml 
baffled flask with 40 µl of a saturated culture resuspended in sterile saline.  The flask was 
incubated with shaking for 1 hour at 37°C before ampicillin was added and grown for 
another 3 hours.  The cells were centrifuged and resuspended in 40 ml of fresh LB.  This 
enrichment was repeated a second time.  After centrifugation, the cells were plated on LB 
plates containing ampicillin and incubated at 37ºC for 24 hours.  The plates were then 
sprayed with penicillinase working solution delivered by a martini mister and incubated 
again at 37ºC for an additional 24 hours. 
Colonies were scored individually for increased persistence to ampicillin using the 
high persistence assay, described below.  Spots that showed confluent growth were scored as 
having high persistence to ampicillin. 
High persistence assays.  Strains were inoculated in 100 µl or 200 µl of LB broth 
with appropriate antibiotics in 96-well microtiter plates, covered with parafilm and grown 
overnight with shaking at 37°C.  Each well was diluted 1:1000 into fresh media, covered 
with parafilm, and incubated for 1hr before spotting 5-10 µl from each well onto 100 mm 
square LB plates containing ampicillin.  After growth for approximately 24 hours at 37°C, 
the plates were spayed with approximately 150 µl of penicillinase working solution and again 
cultured overnight at 37°C.  The next morning, spots were inspected; high persistent mutants 
typically showed confluent growth, while control strains yielded only a few colonies (Figure 
2.1). 
To better quantify persistence, assays were performed by diluting overnight cultures 
were diluted to 1×10-3, 1×10-5 and 1×10-6 in LB.  100 µl of the 10-3 and 10-5 dilutions were 
plated on LB with ampicillin while the 10-6 dilution was plated on LB.  Cultures were plated 
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in triplicate and grown 24 hours at 37°C before being sprayed with 150µl of penicillinase 
working solution and again incubated overnight at 37°C.  The number of colonies on each 
plate was counted and the level of persistence was calculated. 
MIC determination.  Using sterile cotton swabs, overnight cultures were spread 
evenly onto 150 x 15 mm Mueller-Hinton II plates (Becton Dickinson and Co., Franklin 
Lakes NJ).  Five different antibiotic strips were transferred to each plate (as directed by the 
manufacturer), and incubated overnight at 37ºC.  MIC values were determined by recording 
the antibiotic concentration on the strip that intersected with the point of visible inhibition of 
bacterial growth. 
Assay for persistence to other antibiotics.  20 µl from a 5 ml overnight culture was 
transferred to a 125 ml baffled flask containing 20 ml of LB.  After incubation for one hour, 
0.5 ml was transferred to test tubes containing 0.5 ml of LB media with ampicillin, ofloxacin, 
chloramphenicol, kanamycin, or piperacillin with 2x antibiotic concentrations.  At the same 
time, 1:10 serial dilutions of the flask contents were diluted and plated on LB or plated on LB 
with ampicillin.  The tubes were incubated for 4.5 hours at 37ºC, 1:10 serial dilutions were 
plated on LB.  Cultures containing ofloxacin and kanamycin were collected by centrifugation 
and resuspended in fresh LB before diluting to minimize transfer of antibiotics.  All plates 
were incubated overnight at 37°C.  Ampicillin plates were sprayed with penicillinase after 
the first incubation and incubated again for 24 hours.  All plates were incubated at room 
temperature for an additional 5 days to allow cells with delayed growth to form colonies.  At 
least 5 antibiotic tests were done on each strain using multiple plates. 
Growth rates of high persistent mutants.  20 µl of overnight cultures were 
transferred to 20 ml of LB contained in a 125 ml baffled flask and incubated at 37°C with 
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shaking.  Every 30 minutes an OD600 reading was recorded using a Bio-Rad Smartspec 3000 
spectrophotometer. 
Effect of growth phase on persistence.  20 µl from a 5 ml overnight culture was 
transferred to a 125 ml baffled flask containing 20 ml of LB.  At various times 20 µl samples 
were removed from the cultures and 1:10 serial dilutions were plated on LB plates to assay 
the CFU/ml and on ampicillin plates.  At the same time, 500 µl were removed and added to 
5ml cultures of LB with ampicillin or ofloxacin.  The 5ml cultures were incubated at 37ºC for 
4.5 hrs. and diluted in several 1:10 serial dilutions before being plated on LB plates.  The 
ofloxacin culture was washed once with LB before dilution to minimize transfer of the 
antibiotic. 
All plates were incubated for 24 hours after plating.  Ampicillin plates were sprayed 
with penicillinase after the initial incubation and again incubated for 24 hours at 37ºC.  All 
plates were allowed to incubate for an additional 5 days at room temperature before colonies 
were counted.  Each mutant was assayed at least three times. 
Assaying delayed growth.  To measure the delay in the onset of growth, a protocol 
from Balaban et al. was used (3).  Overnight cultures were diluted and plated on LB plates.  
Colonies were counted at several times during growth at 37°C.  These values were compared 
to the number of colonies observable after 80 hours. 
Isolation of Tn10d markers linked to high persistence.  Strains containing Tn10d 
transposons carried by an F-factor were used as donors for generalized P22 transduction into 
high persistent strains containing the temperature sensitive plasmid pNK972 expressing the 
Tn10 transposase (93).  Tetracycline resistant transductants were selected at 42°C.  The cells 
were pooled and resuspended in 1.5 M NaCl and used as donors for bacteriophage P22 
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generalized transduction into LT2.  Individual tetracycline resistant transductants were then 
screened for high persistence by the spot persistence assay described above. 
Mapping Tn10d insertions by arbitrary PCR.  Arbitrary PCR was used to map the 
locations of Tn10d elements in AS19, AS20, AS23 and AS24.  Two rounds of PCR were run 
using primers listed in Table 2.1.  The first round of arbitrary PCR used the primers ARB3 or 
ARB1 and Tn10L, followed by a second round of PCR that used the primers ARB4 and 
IS10R.  PCR products were gel purified and sequenced by the Iowa State University DNA 
sequencing and Synthesis Facility, Ames IA. 
Recombineering.  Antibiotic resistance markers were inserted into the chromosome 
of S. Typhimurium by recombineering using the Quick and Easy E. coli Gene Deletion Kit 
(Gene Bridges, Dresden Germany) as per the instructions provided by the supplier with the 
following modifications.  1 µg of PCR product was used per recombination reaction.  S. 
Typhimurium was transformed with pRED-ET were grown to mid-exponential phase, 
washed three times with 1 mM MOPS in 20% glycerol and resuspended to 20 µl in MOPS 
solution prior to electroporation (28, 64).  PCR products for recombineering were generated 
using pKD3, pKD4 (24), or pRL27 (50) as templates.  Each plasmid contains an antibiotic 
cassette, either chloramphenicol (pKD3) or kanamycin (pKD4 and pRL27), and an R6K ori.  
Primers were synthesized with ~45-48-bp of homology to the targeted genomic sequence 
along with regions that would allow for the amplification of the template sequence 
(Integrated DNA Technologies, Coralville IA).  In order to maximize the amount of PCR 
product that was recovered, an initial PCR reaction was gel purified to remove the plasmid 
template.  The resulting PCR fragment was used as a template for a second round of PCR 
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using multiple reactions.  The products were pooled and purified using the Qiagen PCR 
purification kit (Qiagen, Valencia CA). 
P22 Transduction and linkage analysis.  2 ml of overnight cultures were combined 
with 8 ml P22 HT broth (~1×1011 PFU/ml in LBEDO broth) and incubated at 37°C 
overnight.  Several drops of chloroform were added, vortexed and aerated for several 
minutes.  Cultures were transferred to a 15 ml Falcon tube without disturbing the chloroform 
and centrifuged at 2.5×g for 10 min.  The supernatant was transferred to several 
microcentrifuge tubes and centrifuge at 14,000 rpm for 30 min at 4ºC.  The supernatant was 
removed and the pellets were combined in 100µl 1.5M NaCl to which several drops of 
chloroform were added.  Overnight cultures of the recipients were grown at 37°C.  100 µl of 
overnight recipient culture was combined with 10 µl of donor lysate (~1×1011 PFU/ml), 
which translates to a multiplicity of infection of ~10.  The cultures were incubated for 15 min 
at 37°C.  900 µl of LB + EGTA was added to each transduction and incubated for 20 min at 
37°C to prevent further infection.  200 µl were plated on LB with EGTA and appropriate 
antibiotics and incubated overnight at 37°C.  Colonies were then scored for the rate of 
cotransduction either by patching on LB agar plates with antibiotics for the cotransduction 
between antibiotic markers or using the high persistence assay for the cotransduction of shp. 
Mapping Tn10d insertions by cloning.  A new technique was developed to more 
efficiently map the location of Tn10d insertions (Victorsen and Phillips, manuscript in 
preparation).  Briefly, genomic DNA was isolated from strains showing linkage between 
Tn10d and high persistence using the MasterPure Complete DNA and RNA Isolation kit 
(Epicentre, Madison WI).  4µg of DNA was digested using 1 µl of one of the following 
restriction enzymes: EcoRI, ScaI, MluI, BsrGI, or BamHI in 20 µl reactions.  Digestions were 
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incubated overnight at 37°C.  After heat inactivation, 50 µl ligation reactions were prepared 
using the entire digestion solution and incubated at 14°C overnight.  The entire ligation 
reaction was used to transform chemically competent pir+ E. coli.  Half the cells were plated 
on LB agar plates with the appropriate antibiotics and grown overnight at 37°C.  Plasmid 
DNA was isolated from recombinant DNA, and sequenced. 
Cloning and complementation.  Genes under the control of their native promoter 
were amplified by PCR using 5’-phosporylated primers and Phusion polymerase (Finnzymes, 
Espoo Finland).  The products were gel purified and ligated into pSMART-LCKan (Lucigen, 
Middleton WI).  The quantitative high persistence assay was used for the complementation 
tests using kanamycin in all plates, and without plating dilutions in triplicate.  The assay was 
repeated at least three times. 
Genes under the control of the araBAD promoter were amplified from genomic DNA 
using rTaq (Takara, Otsu Japan) and cloned using the pBAD TOPO TA expression kit 
(Invitrogen, Carlsbad CA).  Plasmids expressing shpA or shpB individually were digested 
with NcoI to remove the leader peptide sequence present on the pBAD TOPO plasmid before 
being religated.  The ampicillin cassette was interrupted by inserting a spectinomycin 
cassette into the unique ScaI site found within bla.  The quantitative high persistence assay 
was used for the complementation experiments.  Plates were supplemented with 
spectinomycin to maintain selection for the plasmids.  The assays were repeated at least three 
times. 
shpAB regulation.  The shpAB-promoter region was cloned by PCR from genomic 
DNA using shpAB-prom-NheI primers (Table 2.1) into the pCR2.1 vector (Invitrogen, 
Carlsbad CA).  The resulting product included the region upstream of shpAB and contained 
39 
 
 
the putative promoter and ribosome binding site for the genes.  The resulting plasmid was 
digested with NheI, and the insert was gel purified and ligated into the unique XbaI site of 
pLacZ2 (Table 2.2) (40).  This plasmid was then transformed into the strains, LT2, AV53, 
AS24 and AS26 and the resulting transformants were assayed for β-galactosidase activity. 
The β-galactosidase activities of cells grown to mid-log phase or from overnight 
cultures in LB at 37ºC with appropriate antibiotics were measured.  100 µl of mid-log culture 
or 100 µl of a 1:10 dilution of overnight culture were combined with 900 Z buffer (60 mM 
Na2HPO4, 40 mM NaH2PO4, 10 mM KCl, 1mM MgSO4·7H2O, 50 mM β-mercaptoethanol), 
one drop of 0.1% SDS and two drops of chloroform.  Reactions were vortexed for 10 sec and 
equilibrated to 28 ºC.  200 µl of 13.3 mM o-nitrophenyl-β-D-galactopyranoside was added.  
Once a yellow color was observable 500 µl 1 M Na2CO3 was added.  The OD was measured 
at 420, 550 and 600 nm, and the Miller units were calculated (61).  The assays were repeated 
three times. 
RESULTS 
Isolation of high persistent mutants.  Although Salmonella does not contain 
obvious homologues to hipAB, we reasoned that, like the E. coli hip mutants, mutants 
showing elevated levels of persistence could be isolated in Salmonella.  These mutants 
should give new insights into high persistence in this food borne pathogen.  Since the hip 
mutants of in E. coli were the result of specific base pair changes, we mutagenized S. 
Typhimurium with the alkylating agent MNNG and screened for mutants displaying high 
persistence (47).  Since it has been observed that persisters are formed during late 
exponential to stationary phase in E. coli, we allowed the cells to recover in sterile saline for 
18 hours prior to screening for high persistent mutants (3, 49).  Following enrichment of 
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mutagenized bacteria, several mutants were isolated that showed an increase in persistence to 
ampicillin.  A majority of these mutants showed a significant decrease in growth rate, as 
measured by observing colony size and growth rate measurements, and were not 
characterized further.  Those that showed growth commensurate with LT2 were tested for an 
increase in persistence to a second antibiotic, ofloxacin.  Six Salmonella high persistent 
mutants (shp) were isolated in this manner. 
Growth rates.  Although the shp mutants showed growth rates comparable to wild 
type LT2 during exponential growth phase, the mutants showed an extended lag phase 
(Figure 2.3).  This extended lag phase was evident by measuring the time it took for cells to 
form visible colonies after plating without antibiotics selection.  As shown in Figure 2.4, a 
significant number of the shp mutants remained dormant after plating. 
Persistence to other antibiotics.  To ensure that the new mutants imparted 
persistence to multiple lethal treatments, their response to ampicillin, ofloxacin, kanamycin, 
chloramphenicol, or piperacillin was tested.  The number of persisters in mid-log growth 
phase has been shown to remain relatively constant, therefore, cells were grown to mid-lag 
phase prior to exposure (43).  As shown in Figure 2.5, AS13, AS17 and AS18 showed 
between 2 to 3 orders of magnitude increase in persistence to all antibiotics, showing a 
general tolerance to multiple antibiotics. 
In E. coli, the number persistent cells appear to be dependent on the growth phase of 
the culture (3, 49).  In order to determine if persistent cells in Salmonella were also only 
generated during a specific growth phase, we determined the number of persister cells during 
different periods of cell growth (Figure 2.6).  Similar to E. coli, the number of persistent 
Salmonella did not change between lag and early log phase.  However, the number of 
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persistent cells increased dramatically when cells reached mid-exponential phase.  The 
increase was observed in response to both ampicillin and ofloxacin, and a similar result was 
obtained when the experiment was repeated using ampicillin plates, which is a more sensitive 
assay of persistence (Figure 2.7). 
Role of relA in persistence.  RelA is essential for (p)ppGpp synthesis, a molecule 
that signals amino acid starvation in bacteria (9).  Previous reports have indicated that the 
high persistence of hipAB E. coli mutants requires a functional relA gene to impart the high 
persistence phenotype.  Using a relA mutant, Korch et al. showed that the persistence of the 
hipA7 mutant decreased by 3 orders of magnitude (47).  Also, other TA modules like mazEF 
are regulated by (p)ppGpp (1).  To determine if the LT2 hip mutants have a similar 
requirement for functional relA, we constructed a knockout mutation and measured 
persistence in each shp mutant.  No significant change in persistence was observed (Figure 
2.8), indicating that persistence in LT2 can be achieved in the absence of (p)ppGpp synthesis. 
Selectable markers linked to shp.  In order to identify the locus responsible for high 
persistence, we attempted to isolate random insertions of the Tn10d transposon linked to high 
persisters in the mutants.  The resulting strains: AS19 and AS20 were isolated with Tn10d 
linked to the shp mutation in AS13, AS26 and AV1 each contained transposons linked to the 
shp mutation in AS17, and AS23 and AS24 each had a transposon linked to the shp mutation 
in AS18 (Table 2.3). 
Two strategies were used to map the location of these Tn10d insertions.  The 
transposons in the AS13 and AS18 derived strains were mapped by sequencing arbitrary 
PCR products.  The transposons in the AS17 derived strains were mapped using an 
alternative technique developed for this study.  These transposons were retrofitted with an 
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R6K conditional origin of replication to essentially create a “plasposon” (26).  To accomplish 
this, the Tn10ds were recombineered with a PCR product amplified from a region of pKD4 
that included the R6Kγ origin of replication and kanamycin resistance.  Total genomic DNA 
was isolated from the kanamycin resistant, tetracycline sensitive recombinants and digested 
with multiple enzymes, as described in Materials and Methods.  After selecting for 
transformants in a pir+-E. coli strain, plasmid DNA was isolated and sequenced.  DNA 
sequencing revealed that the Tn10d in both AS26 and AV1 had inserted within hsdM, only 1 
base away from the insertion site of AS24 (Table 2.3). 
Cotransduction by P22 is limited to 44,000 bp regions and correlates to the distance 
between the two phenotypes (95).  Once the location of the transposon was known, the 
distance to the shp mutation was approximated by a formula proposed by Wu.  The 
frequency of co-transduction between the transposons and the shp mutations are shown in 
Table 2.3. 
Linkage analyses of Tn10d insertions.  In order to identify selectable markers with 
higher linkage to the persistence genes, we used recombineering to insert either kanamycin or 
chloramphenicol resistance at various locations surrounding the Tn10d elements.  We 
initially chose insertion sites based on the linkages of the Tn10d transposons.  However, after 
repeated rounds of inserting new markers in this fashion, the rate of cotransduction remained 
very low.  Therefore, we systematically inserted markers roughly every 5-kbp within the 
region surrounding our Tn10d markers that could be transduced by P22.  Based on the Wu 
formula, the linkage of markers less than 3-kbp away from the shp allele should be at least 
80%, well above the levels we had seen in our initial attempts to isolate linked markers (95). 
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Using this approach, we found that the high persistence mutation of AS17 and AS18 
were very close to the insertion near mrr.  The high persistence in AS13 mapped close to an 
insertion near metG.  The cotransduction between the high persistence mutations and the 
recombineered markers are shown in Table 2.3. 
Mapping the high persistence locus of AS13.  Based on the linkage data, it 
appeared the mutation of AS13 was very close to metG, as insertion of kan immediately 
downstream of the metG coding region was 96.4% linked with high persistence.  To 
determine if the shp mutation lay upstream or downstream from the kan site, a 5.3-kbp region 
downstream of metG was deleted.  The metG-KD4.S and 2161-KD4.AS primers (Table 2.1) 
were used to generate a PCR product that was introduced to AS13 by recombineering (Figure 
2.9).  Although this region contains several uncharacterized genes, the level of persistence 
did not decrease in the AS13 derivative mutant, suggesting that the mutation lay upstream 
from the insertion site, likely in metG, encoding methionyl-tRNA synthetase. 
To determine if the mutation was in metG, we cloned the entire coding region from 
wild type LT2 onto the low copy number plasmid pSMART-LCKan and attempted to 
complement the high persistence phenotype.  As shown in Figure 2.10, persistence levels 
returned to those found in wild type LT2.  We also cloned metG from AS20 and found that it 
also complemented the shp mutation. 
DNA sequence analysis of the gene from AS20 confirmed that there was a mutation 
in metG.  The metG418 allele from AS13 contained a four base pair deletion at position 1877 
within metG.  The deletion of TGAT results in a frame shift mutation, resulting in a 
premature stop codon that truncates the last 47 amino acids of the gene product. 
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Mapping the high persistence locus of AS17 and AS18.  To identify the location of 
the high persistence mutation with respect to mrr, we used the mrr-KD4.S and 4535-KD4.AS 
primers to generate a PCR product to delete a region between mrr and STM4535 (Figure 
2.9).  The resulting deletion mutant lost high persistence, restoring levels to that of LT2 and 
indicating that the shp mutation was located within the region between mrr and STM4535, as 
shown in Figure 2.11. 
To further identify the shp alleles, we deleted the predicted genes identified as 
STM4528 and STM4529, the first putative operon within this region.  Deleting these putative 
genes also restored the level of persistence to that of the wild type control strain (Figure 
2.11).  STM4528 and STM4529 were cloned from both AS17 and AS18 and sequenced.  
Both mutants contained identical C to T transition mutations in the second gene, STM4529, 
of the putative operon.  As shown in Figure 2.13, the result is a nonsense mutation resulting 
in a truncation of 4 amino acids of the predicted gene product. 
Complementation of high persistence.  To perform complementation tests, 
STM4528 and STM4529 from both wild type LT2 and AS17 were cloned into the low copy 
number plasmid pSMART-LCKan and introduced to AS17 by electroporation.  The AS24 
transformants showed a decrease in the level of persistence, suggesting that the shp mutation 
in these strains is recessive.  Likewise, when AS24 was transformed with the plasmid 
expressing STM4528 and STM4529 from the shp mutant, the level of persistence was also 
reduced (Figure 2.12) 
Since STM4528 and STM4529 were clearly responsible for the high persistence 
phenotype in S. Typhimurium, the ORFs were renamed shpA and shpB and the mutant allele 
of shpB referred to as shpB1.  Comparison of shpA and shpB with the genomes of all other 
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completely sequenced prokaryotic genomes, including other species of Salmonella, using 
BLAST revealed no significant matches.  However, given the relatively small size of the 
shpA and shpB coding regions predicted to code for polypeptides of 95 and 100 amino acids 
respectively, and the tandem arrangement of the genes, we considered that these genes may 
encode a TA module, which show similar structural characteristics.  To test this, we cloned 
shpA and shpB together, as well as individually, into pBAD-TOPO in order to regulate 
transcription of the genes by arabinose.  Each plasmid was also modified by insertion of a 
spectinomycin (spc) resistance gene to disrupt bla, which encodes ampicillin resistance, so 
that persistence could be assayed using ampicillin. 
While S. Typhimurium transformants expressing shpA and shpB gave rise to colonies 
indistinguishable from the pBAD-TOPO-spc control plasmid, transformants expressing shpA 
alone were small with reduced viability in the presence of arabinose (Figure 2.16).  Similar 
results were also seen with E. coli transformants, although the lethal effects of shpA 
expression were even more pronounced (data not shown). 
Using these plasmids, we observed that shpB1 was complemented by shpB+ or 
shpAB+, even without the addition of arabinose (Figure 2.14).  Furthermore, no decrease in 
persistence was observed in the mutant strain when transformed with the plasmid expressing 
shpAB1, while only a slight decrease was seen when transformed with the mutant shpB1 
alone.  Conversely, we were able to induce a higher level of persistence by expressing the 
mutant shpAB1 in the ∆shpAB strain AV53 (Figure 2.14).  This increase in persistence was 
not achieved through expression of the shpB1 allele alone, however. 
Expression of shpAB.  Another characteristic of TA modules is that they are 
frequently autoregulated (6, 36, 58, 77).  To determine if this is also true of shpAB, we 
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constructed a gene fusion where expression of lacZ was placed under control of the putative 
shpAB promoter.  The β-galactosidase activity was measured in wild type LT2, 
AV53(∆shpAB) and AS24 (shpB1) transformed with a plasmid expressing the lacZ construct.  
As shown in Table 2.4, the results indicated that shpAB is autoregulated, as the expression of 
lacZ increased in the absence of a wild type copy of shpB.  This result also indicates that the 
shpB1 mutant is defective in autoregulation as β-galactosidase expression was even higher 
than in the shpAB deletion mutant AV53. 
Predicted TA modules in Salmonella.  Given the broad distribution of TA modules 
in bacteria, we sought to identify other genes that potentially encode toxin/antitoxin genes.  
We used the RASTA-bacteria program to identify additional putative TA modules encoded 
by the Salmonella Typhimurium LT2 genome (78).  Genes with a score above 70%, their 
predicted associated genes, and shpAB are listed in Table 2.6.  Interestingly, shpAB scored 
51.6 and 27 respectively on the scale, below the cut off typically used to identify TA modules 
with a high confidence. 
DISCUSSION 
We have successfully isolated several mutant strains of Salmonella Typhimurium 
strain LT2 that show an increased level of persistence when exposed to multiple antibiotics.  
While most of these mutants grew slower than the wild type Salmonella strain LT2, several 
appeared to grow at a comparable rate and were chosen for further characterization.  Upon 
closer examination, these mutants in general showed a prolonged lag phase before beginning 
growth comparable to LT2 (Figure 2.3).  Furthermore, they did not exhibit higher antibiotic 
resistance, rather they were able to better tolerate antibiotic exposure (Figure 2.2 and Figure 
2.5).  We designated these alleles as shp for Salmonella high persistence. 
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Characterization of the shp mutants revealed that the persister cells are generated 
during mid to late log phase (Figure 2.6 and Figure 2.7).  This is similar to what has been 
observed in the hipA7 high persistent E. coli strain (3, 43).  Unlike the hipA7 strain however, 
the generation of persister cells was independent of (p)ppGpp synthesis (Figure 2.8).  
(p)ppGpp functions as a signaling molecule reporting amino acid starvation (9).  Due to this 
difference between the hipA7 mutation and our shp mutants, it seemed likely that the shp 
mutants were unrelated to hipA. 
We further observed that a significant fraction of the shp mutants remained dormant 
for an extended period after plating on LB agar plates (Figure 2.4).  Compared to wild type, 
the mutants took longer to form the same number of countable colonies.  Since antibiotics are 
most effective against actively growing bacteria, these results suggest an explanation for high 
persistence.  A subpopulation the shp mutant cells appear to delay their growth, even under 
favorable conditions, and in doing so are able to avoid the lethal effects of antibiotics.  
Unlike slow growing mutants however, where all of the cells grow at identical rates, the shp 
mutants represent a heterogeneous population of bacteria where only a subpopulation of cells 
are tolerant of antibiotics. 
In order to better understand the mechanisms the shp mutants employ to delay growth 
and increase persistence, we used a combination of genetic and molecular approaches to 
identify the responsible genes.  We first created a random pool of Tn10d mini-transposon 
insertions carrying a tetracycline resistance marker (TetR) in the shp mutants.  Using 
generalized transducing bacteriophage P22, we isolated insertions that were linked to the shp 
mutations.  Bacteriophage P22 was then grown on the pooled, randomized TetR mutants and 
used to infect wild type LT2.  The TetR transductants were screened for high persistence 
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using the spot high persistence assay described in the Materials and Methods.  Three mutant 
strains, AS13, AS17 and AS18 were found to cotransduce high persistence with TetR.  We 
believe that the remaining strains may have been the result of multiple mutations, since 
linked TetR markers were not found. 
Two methods were used to determine the location of the linked Tn10d elements.  The 
Tn10d in AS13 was mapped by arbitrary PCR as described by Das et al (23).  A DNA 
fragment was amplified from genomic DNA using the primers Tn10L and ARB3.  This 
product was in turn used as a template for a second round of PCR using the primers IS10R 
and ARB4.  This amplified a smaller fragment, within the original PCR fragment, which was 
sequenced in order to determine the location of the Tn10d. 
A second strategy was also developed to improve the efficiency of mapping the 
Tn10d elements (Victorsen and Phillips, manuscript in preparation).  This method took 
advantage of recombineering to convert the Tn10d into a plasposon.  When a conditional 
origin of replication was inserted within the transposable elements, plasmids could be created 
through the digestion and ligation of genomic DNA.  The plasmids that contained the 
recombineered ori, when transformed into pir+ strains, are able to replicate allowing the 
location of the Tn10d to be determined by sequencing plasmid DNA. 
Since the linkage between TetR and high persistence was relatively low, < 20% (Table 
2.3), we used recombineering to target additional selective markers in the vicinity of the 
Tn10d insertions.  As described in Materials and Methods, we used recombineering to insert 
kanamycin resistance KanR markers throughout the genome surrounding the transposon 
insertion sites.  This yielded several KanR markers that had a linkage of >90% (Table 2.3). 
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Unfortunately, we were not able to accurately predict persistence genes based upon 
the Salmonella genomic sequence in order to guide our mapping efforts.  For example, 
Tn10d linkage data initially suggested that the shp mutation in AS13 was near a group of 
genes encoding the two-component regulatory system baeRS.  Associated with baeRS, are 
genes encoding a multidrug transporter (4).  To determine the involvement of these loci in 
high persistence we used recombineering to separately delete baeRS and STM2126/yegNOB.  
Assays of persistence in these strains showed there to be no change in the level of 
persistence.  Although these genes could have feasibly caused high persistence, upon 
repeating the linkage experiments it was clear that these were not close to the shp mutation as 
we had originally thought. 
The lack of accuracy in mapping high persistence to the Tn10d markers may be due 
to the relative inefficiency of growing P22 on the mutations that show subtle changes in 
growth kinetics.  However, continual use of recombineering to introduce selectable markers 
eventually proved successful, and the high persistence mutation in AS13 was mapped to a 
location near metG.  A KanR marker was inserted just downstream of metG, which encodes 
methionyl tRNA-synthetase, and was found to show high linkage to persistence (96.4%).  
Downstream of this insertion were several ORFs of unknown function.  To assess their 
contribution to persistence we deleted a region containing 6 ORFs.  This deletion mutant 
however, showed no significant difference in persistence from wild type LT2 (data not 
shown). 
Since metG is an essential gene, and could not be deleted, we attempted to 
complement the high persistence of AS20.  To accomplish this, metG was cloned by PCR 
from wild type LT2 onto a low copy number plasmid.  When AS20 was transformed with the 
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metG-expressing plasmid, persistence returned to a level comparable to wild LT2 (Figure 
2.10).  We also cloned metG418 from AS20, and upon repeating the assay, also observed 
lower levels of persistence.  Although this result was somewhat unexpected, we attribute it to 
expressing of the mutant metG418 from a multiple-copy plasmid.  This was also observed 
with hipA7 in E. coli when it was expressed on a multicopy plasmid (63). 
In order to identify the mutation in metG418, we sequenced the mutant allele from 
AS20 and found that it contained a 4-bp deletion that resulted in a frame shift leading to a 
premature stop codon.  This mutation results in a truncation of the last 47 residues in the C-
terminal domain (CTD) of MetG. 
Prior studies of MetG from E. coli have shown the CTD is necessary for dimerization 
of the protein, as well as additional binding to tRNA (11, 21).  These two activities enable 
MetG to demonstrate anti-cooperative binding (8, 27).  The first binding site has a higher 
affinity for tRNA, likely due to its interaction with one of the CTDs.  At high concentrations 
of free tRNA, the second subunit binds a second tRNA aiding in the disassociation of the 
tRNA bound to first subunit, resulting in an increased kcat under these circumstances.  It has 
also been proposed that the affinity of the CTD for tRNA may also allow it to regulate 
translation by binding to a tRNA-like structure in within the 5’ end of its own mRNA (22). 
While the manner in which MetG can increase the level of persistence remains 
unclear, these functions of the CTD provide some insight as to the possible ways in which 
MetG could affect persistence.  Loss of the ability to dimerize, and likely lowering of the 
affinity of MetG for tRNAMet, may starve the cell of Met-tRNA stalling protein synthesis.  
Another likely possibility that would result in a similar situation is if the loss of the CTD 
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affects protein stability.  However, the loss of the CTD may be affecting persistence 
indirectly either through translational regulation or by inducing a cell stress response. 
Using recombineering we also created several additional deletions mutations to 
identify the alleles responsible for persistence in AS17 and AS18.  The insertion near mrr 
was 91.7% and 96.4% linked respectively with high persistence.  Therefore we deleted two 
small ORFs of unknown function, STM4528 and STM4529.  Deletion of both genes lowered 
persistence to the levels seen in LT2 (Figure 2.11).  To further characterize these genes, they 
were cloned from both wild type LT2 and AS18 and complementation tests preformed.  
Expression of either the wild type or mutant alleles complemented the high persistence of 
AS17 and AS18 (Figure 2.12). 
Sequencing the two ORFs from wild type and both mutants revealed the second gene 
in the putative two gene operon contained a nonsense mutation that would result in truncation 
of the last four residues from the gene product.  The identical mutation was also found in 
AS18, and is consistent with their similar behavior in experiments to characterize high 
persistence (Figure 2.3, Figure 2.4, Figure 2.5 and Figure 2.8).  Since these two ORFs were 
associated with high persistence they were named shpAB (Salmonella high persistence), and 
the mutant allele was referred to as shpB1. 
To further understand how each ORF contributes to persistence, shpAB from wild 
type LT2 and AS24 was cloned, both together and individually, under the control of the 
araBAD promoter from E. coli (66).  This E. coli promoter is functional and tightly regulated 
in Salmonella.  Even without arabinose, expression of shpB+ complemented the shpAB1 
mutants, as did expression from the mutant shpAB1 allele (Figure 2.14) indicating some level 
of transcription still occurs in the absence of arabinose. 
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To clarify the role of shpAB in persistence, we also performed complementation tests 
in AV53, an LT2 mutant that was deleted for shpAB.  When shpAB1 were expressed together 
in AV53, high persistence was observed (Figure 2.14).  However, expression of shpB1 alone 
did not induce persistence suggesting that shpA is actually causing persistence. 
If this were the case, expression of shpA alone should increase persistence.  
Expression of shpA in LT2 was able to increase persistence, but not to the levels seen in the 
original mutants (Figure 2.15).  This result may be due to the toxicity caused by expression 
of shpA. 
When constructing plasmids for complementation tests, we observed that E. coli 
transformants expressing shpA alone grew poorly and were inviable upon addition of 
arabinose (data not shown).  Transformants expressing shpB, shpB1, shpAB or shpAB1 
however, grew normally.  Similar results were also seen for the Salmonella transformants 
(Figure 2.16). 
These results strongly suggest that shpAB represents a new TA module where the 
product of shpB is an antitoxin that prevents the lethal effects of ShpA through direct 
interaction.  Typically, TA modules encode relatively small proteins, similar in size to the 
predicted gene products of shpA and shpB, and are found in a tandem orientation in the 
chromosome(30).  Although most TA modules have a structure where the toxin is encoded 
by the downstream open reading frame, shpAB is similar in structure to higBA where the 
orientation is reversed (19).  Furthermore, it appears that the target of ShpA is conserved in 
both Salmonella and E. coli, as ShpA is toxic in both species (Figure 2.16, data not shown). 
Another feature of TA modules is that they are autoregulated (6, 36, 58, 77).  To test 
if this also holds true for shpAB, we constructed a reporter gene fusion where the putative 
53 
 
 
promoter of shpAB and a region of shpA encoding the first few amino acids were fused to 
lacZ.  The β-galactosidase assays demonstrate that shpAB expression was elevated in the 
absence of shpAB (AV53), as well in the shpB1 mutant (Table 2.4). 
While not tested directly, these results are consistent with the behavior of other TA 
modules where the toxin, ShpA, forms a complex with ShpB in vivo.  This complex serves 
both to inactivate the growth inhibition of the toxin, as well as function as a repressor of 
transcription of the TA module. 
The shpAB locus is located in a region that has been dubbed the immigration control 
region for its abundance of restriction-modification systems (81).  This region is highly 
variable between bacteria.  Neither shpA nor shpB share significant homology to any 
characterized genes including other characterized TA modules.  Using the web-based 
program RASTA-bacteria, neither shpA nor shpB was predicted to belong to a TA module 
(Figure 2.6) (78).  This program searches both for homology to known TA modules, as well 
as for several motifs of TA modules such as short overlapping ORFs.  The program predicted 
27 genes in S. Typhimurium as having a high probability of encoding a TA module.  While 
fifteen of the genes had previously been predicted by homology alone (Table 2.5), the 
remaining TA modules remain uncharacterized (69).  Interestingly, both shpA and shpB gave 
relatively low probability scores and would not be considered as belonging to a family of TA 
modules.  This result also suggests that additional, as yet identified TA modules are encoded 
by the S. Typhimurium chromosome. 
Discovery of shpAB in Salmonella represents the second example of a TA module 
that is involved in persistence, and the first example in Salmonella.  We propose a similar 
model for the function of shpAB persistence in S. Typhimurium.  Through an unknown 
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cellular trigger, the balance of toxin to antitoxin changes, leading to increased expression and 
activity of the toxin protein.  By targeting an essential cellular process, the toxin is able to 
halt growth, leading to the formation of persistent cells.  By this model, the shpB1 mutation 
elevates the toxin levels and activity even in the absence of environmental stress, leading to 
an elevated number of persisters.   
Despite these similarities, there are differences in the systems.  For example, while 
hipAB is dependent on (p)ppGpp synthesis, shpAB is not.  The mutation in hipAB was within 
the toxin gene hipA, the mutation in shpAB was the result of a mutation in the antitoxin shpB. 
Future studies will be required to better understand how shpAB contributes to 
persistence in Salmonella, including identifying the target of ShpA.  Our results also suggest 
that there are additional TA modules to be discovered in the Salmonella genome.  The fact 
that shpAB is unrelated to hipAB yet can also cause persistence further supports the idea that 
there is redundancy in the function of TA modules.  Insights from continued study of 
persistence in Salmonella will likely be applicable to all bacteria. 
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TABLES AND FIGURES 
Primer Sequence 
Arbitrary PCR ARB1 5' - GGC CAG GCC TGC AGA TGA TGN NNN NNN NNN CAT AT - 3' 
 ARB2 5' - GGC CAG GCC TGC AGA TGA TG - 3' 
 ARB3 5' - GGC CAC GCG TCG ACT AGT ACN NNN NNN NNN ACG CC - 3' 
 ARB4 5' - GGC CAC GCG TCG ACT AGT AC - 3' 
 IS10R2 5' - CAA GAT GTG TAT CCA CCT TAA CTT AAT GAT TTT - 3' 
Recombineering tetA-KD4.S 5' - ATG AAT AGT TCG ACA AAG ATC GCA TTG GTA ATT ACG TTA CTC GAT CTT ACA TGG CGA TAG CTA GAC TGG - 3' 
 tetA-KD4.AS 5' - AGC ACT TGT CTC CTG TTT ACT CCC CTG AGC TTG AGG GGT TAA CAT GAA GGA GTC AGG CAA CTA TGG ATG AAC - 3' 
 yegE-KD4.S 5' - CTA AAC ATG CTG GTG CGC GGC GAC ATC AAC AGC TAT TCC ATG GAA GTG TAG GCT GGA GCT GCT TC - 3' 
 yegE-KD4.AS 5' - GAG CAA TAA AAT AGA GAG GTT TAT TGT CTT TAT GAC GAA CCA GTG CAT ATG AAT ATC CTC CTT AG - 3' 
 yjiJ-KD4.S 5' - AGC CGC TGA TAG GTC AGC TTG CGC CCT AAG AAT CCT ACG GGC AGG TGT ACA CTT ACA TGG CGA TAG CTA GAC TGG - 3' 
 yjiJ-KD4.AS 5' - TTA TAT ACC CTT CCT ACT TCA AGT GGC TTA TGT GTT GGC TAC GGA GAG CTC GGA GTC AGG CAA CTA TGG ATG AAC - 3' 
 baeR-KD4.S 5' - CTT TCC TTT GGC CGA GCG GTA TCC CGA AAA CCA CGA CGA ACG CGA TGT GTA GGC TGG AGC TGC TTC G - 3' 
 baeR-KD4.AS 5' - TAT CGG TAA ACT AAA AAG AGC GGC CAA ATA ATT TAT TGT CCC CGA CAT ATG AAT ATC CTC CTT AG - 3' 
 yjjQ-KD4.S 5' - TGT TCT TTT TAT CTA AAC CAT CCA GCC CCT TGA TCC CGC CAA TAA GTG TAG GCT GGA GCT GCT TC - 3' 
 yjjQ-KD4.AS 5' - CAT GAG GTA ATT TTC ATG TTT CAT ACG ACG AAT CCC GTC AGC AAG CAT ATG AAT ATC CTC CTT AG - 3' 
 yegD-KD4.S 5' - GTT GCG TAG CGC CTC GCA AAG CGG GTC GCC ATT CAG AAT AAT CCC TGT GTA GGC TGG AGC TGC TTC G - 3' 
 yegD-KD4.AS 5' - GTC AGC AGG GAA GGG AGA AAA ATG GAG GAA TTA TGG AAC ACG GTC CAT ATG AAT ATC CTC CTT AG - 3' 
 yeg3-KO.AS 5' - TTA CAC CAT TGA GTT GAC CTG TCC CGG CAG CTC TGA ATT CGG GAT CAT ATG AAT ATC CTC CTT AG - 3' 
 4502-KD4.S 5' - TTT TCG CAC CAG TGA TGA TAT TGT ATG GAT TCT TTG CGC AAG CCA TGT GTA GGC TGG AGC TGC TTC G - 3' 
 4502-KD4.AS 5' - TTT ACT CTA CAG ATA ATT GTA ACC CAT CGC CCT TTG TCA TTC TGC CAT ATG AAT ATC CTC CTT AG - 3' 
 trpS2-KD4.S 5' - AAA GTC ATA TCG CCT GAA CAG ATA ACA TCT CAC TGA CTT TGA AAC TGT GTA GGC TGG AGC TGC TTC G - 3' 
 trpS2-KD4.AS 5' - GCC TTT CAG CGC CAC GTA TTT TTG GGC AGC AAA TTA TAA AAT CGC CAT ATG AAT ATC CTC CTT AG - 3' 
 4518-KD4.S 5' - AGG CGA TAG AAA CAG CGG CTG CGG ATG TAC TGA ATT TCA TGT AAT TGT GTA GGC TGG AGC TGC TTC G - 3' 
 4518-KD4.AS 5' - AGA ACG CGT CTC TTC CTG TCT GTG TTT TCA CCG GCA GCG TTT TTG CAT ATG AAT ATC CTC CTT AG - 3' 
 4535-KD4.S 5' - TTC CCT CTG TTA ACC CGC ATC TTT TTT CGG CGC GCC ACT TTT TCT TGT GTA GGC TGG AGC TGC TTC G - 3' 
 4535-KD4.AS 5' - TCT AAA ACA CAT TCC ACT GTG ATA AAA GAG AGC AAG CGG CGT GCC CAT ATG AAT ATC CTC CTT AG - 3' 
 mrr-KD4.S 5' - ATT ACT TTG AGT AGT GGT AAC GCT GGA ACC TGA TTG CGG GTA ATT TGT GTA GGC TGG AGC TGC TTC G - 3' 
 mrr-KD4.AS 5' - TTC TGG GCG AGA GGA AAC ACA GGT GCC CAC AAC GTG GTC CAT CTC CAT ATG AAT ATC CTC CTT AG - 3' 
 yegV-KD4.S 5' - ATG CTG TAT TCA ATA GGC CGC TGC TGC TGA TCG AGC GCC ACC TGC TGT GTA GGC TGG AGC TGC TTC G - 3' 
 yegV-KD4.AS 5' - GTC GCA TAT TCA AAT GGA TGG TAA AGT GCC GGT GCT GGT GAT TAA CAT ATG AAT ATC CTC CTT AG - 3' 
 metG-KD4.S 5' - TAA GCA ACA AGC CGG AGC ATG CTC CGG CTT TTT TAA CCG CTT AAT TGT GTA GGC TGG AGC TGC TTC G - 3' 
 metG-KD4.AS 5' - AAG GAA AAA GTT AAA ACA CGC GGA TGG GGT GAT ATG CCA GTC AGG CAT ATG AAT ATC CTC CTT AG - 3' 
 2161-KD4.S 5' - TAA ACA GAA GCT AAC AAA TTC GCT TTA ATG TAT ACT CCT TTT ATT TGT GTA GGC TGG AGC TGC TTC G - 3' 
 2161-KD4.AS 5' - CGA TCA CCC CGA TTT TCG CTA CGC GCA TTA TGT ACT CCT TAT GTT CAT ATG AAT ATC CTC CTT AG - 3' 
 yjiX-KD4.AS 5' - AAC TGA TGC CGG GTA GCG CAC AGC GAC CCC GGC TAG TGT AGG CCG CAT ATG AAT ATC CTC CTT AG - 3' 
 4529-KD4.AS 5' - CAT TAA GCG CTT ATC TGG CCT GGC GGG AAT TTG TAG GCC GGA TAA CAT ATG AAT ATC CTC CTT AG - 3' 
 yehR-KD4.S 5' - ATG AAA ATT TCT GGC AAG TTA TTG TCC GCG GCT TTG GCT TCC GTA TGT GTA GGC TGG AGC TGC TTC G - 3' 
 2156A-KD4.AS 5' - ATT GAT TCT ATG ATA TCC GCT CTC TTC CAG CAG TTT CTG CGA GCG CAT ATG AAT ATC CTC CTT AG - 3' 
Cloning STM4528.S 5' - GGC GTA TCC TCA CGT TTA CTC AAG - 3' 
 STM4529.AS 5' - GGG AAT TTG TAG GCC GGA TAA G - 3' 
 STM4528-ara.S 5' - ACC ATG GAG TTT GAA TGG GAT GCG AAC - 3' 
 STM4528-ara.AS 5' - GAT GCG TTG CCG CGT TTA TGT T - 3' 
 STM4529-ara.AS 5' - GGG AAT TTG TAG GCC GGA TAA G - 3' 
 STM4529-ara.S 5' - ACC ATG GGA AGC ATG GTT AAA CAT AAA CGC GGC - 3' 
lacZ reporter shpAB prom-NheI.S 5' - GCT AGC AAA GTT GAA GGT CTG GTG CTG GTG - 3' 
 shpAB prom-NheI.AS 5' - GCT AGC CTT GTT CGC ATC CCA TTC AAA CTC - 3' 
Table 2.1.  Primers used in this study.  The underlined sequences in the recombineering 
primers represent the portion of the primers that will anneal to pKD3 and pKD4. 
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Strain or plasmid Description 
Parent strain or 
plasmid Source 
Strains    
DH5α E. coli cloning strain   
LMG194 wild type E. coli  Invitrogen 
EPI400 E. coli pcnB4 strain  Epicentre 
EC100D E. coli pir+ strain  Epicentre 
LT2 wild type Salmonella 
Typhimurium 
 SGSC 
AS13 LT2 metG418 LT2 this paper 
AS17 LT2 shpB1 LT2 this paper 
AS18 LT2 shpB1 LT2 this paper 
AV7 relA::kan LT2 this paper 
AV15 yegE::kan LT2 this paper 
AV18 zef::cam LT2 this paper 
AV19 zji::kan LT2 this paper 
AV20 zef::kan LT2 this paper 
AV21 zjh::kan LT2 this paper 
AV29 ∆(STM2126-baeR)::kan LT2 this paper 
AV35 ∆(STM2131-
STM2135)::kan 
LT2 this paper 
AV46 ∆(STM4528-
STM4534)::kan 
LT2 this paper 
AV53 ∆(STM4528-
STM4529)::kan 
LT2 this paper 
AV56 ∆(STM4528-yjiX)::kan LT2 this paper 
AV59 ∆(yehR46-
STM2156A)::kan 
LT2 this paper 
AV61 ∆(STM4528-
STM4529)::cam 
LT2 this paper 
AV62 ∆(yehR-yehV)::kan LT2 this paper 
AS19 stcC::Tn10d AS13 this paper 
AS20 yegS::Tn10d AS13 this paper 
AV9 relA::kan AS13 this paper 
AS26 hsdM::Tn10d AS17 this paper 
AV1 hsdM::Tn10d AS17 this paper 
AV8 relA::kan AS17 this paper 
AS23 STM4536::Tn10d AS18 this paper 
AS24 hsdM::Tn10d AS18 this paper 
AV16 yegE::kan AS20 this paper 
AV28 zef::kan AS20 this paper 
AV30 ∆(STM2126-baeR)::kan AS20 this paper 
AV34 ∆(STM2131-
STM2135)::kan 
AS20 this paper 
Table 2.2.  Strains and plasmids used in this study. 
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Strain or plasmid Description 
Parent strain or 
plasmid Source 
AV41 ∆(STM2126-baeR)::kan AS20 this paper 
AV49 zef::kan AS20 this paper 
AV50 zeg::kan AS20 this paper 
AV51 zeg::kan AS20 this paper 
AV52 zeg::kan AS20 this paper 
AV60 ∆(yehR-STM2156A)::kan AS20 this paper 
AV63 ∆(yehR-yehV)::kan AS20 this paper 
AV17 zji::kan AS24 this paper 
AV42 zji::kan AS24 this paper 
AV43 zji::kan AS24 this paper 
AV44 zji::kan AS24 this paper 
AV47 ∆(STM4528-
STM4534)::kan 
AS24 this paper 
AV55 ∆(STM4528-
STM4529)::kan 
AS24 this paper 
AV58 ∆(STM4528-yjiX)::kan AS24 this paper 
AV14 tetA::kan AS26 this paper 
AV31 zjh::kan AS26 this paper 
AV37 zji::kan AS26 this paper 
AV38 zji::kan AS26 this paper 
AV39 zji::kan AS26 this paper 
AV40 zjh::kan AS26 this paper 
AV45 zji::kan AS26 this paper 
AV48 ∆(STM4528-
STM4534)::kan 
AS26 this paper 
AV54 ∆(STM4528-
STM4529)::kan 
AS26 this paper 
AV57 ∆(STM4528-yjiX)::kan AS26 this paper 
AV13 tetA::kan AV1 this paper 
Plasmids    
pRED-ET Recombineering plasmid  Genebridges 
pCR2.1 Cloning vector  Invitrogen 
pBAD-TOPO Expression vector  Invitrogen 
pSMART-LCKan KanR Low copy cloning 
vector 
 Lucigen 
pNK972 Tn10 transposase plasmid  (93) 
pAV1-sac Genomic plasmid by 
digestion with SacI 
AV13 this paper 
pAV1-mlu Genomic plasmid by 
digestion with MluI 
AV13 this paper 
Table 2.2.  Continued.    
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Strain or plasmid Description 
Parent strain or 
plasmid Source 
pAS26-mlu Genomic plasmid by 
digestion with MluI 
AV14 this paper 
pLacZ2 Promoterless lacZ cloning 
vector 
 (40) 
pAS20 MetG metG from AS20 pSMART this paper 
pLT2 MetG metG from LT2 pSMART this paper 
pLT2 shpAB shpAB from LT2 with 
native promoter 
pSMART this paper 
pAS24 shpAB shpAB from AS24 with 
native promoter 
pSMART this paper 
pAS26 shpAB shpAB from AS26 with 
native promoter 
pSMART this paper 
pBAD LT2 shpAB-1 shpAB from LT2 pBAD-TOPO this paper 
pBAD AS24 shpAB-1 shpAB from AS24 pBAD-TOPO this paper 
pBAD shpA-1 shpA from LT2 pBAD-TOPO this paper 
pBAD LT2 shpB-1 shpB from LT2 pBAD-TOPO this paper 
pBAD AS24 shpB-1 shpB from AS24 pBAD-TOPO this paper 
pBAD shpA-2 without NcoI fragment pBAD shpA-1 this paper 
pBAD LT2 shpB-2 without NcoI fragment pBAD LT2 
shpB-1 
this paper 
pBAD AS24 shpB-2 without NcoI fragment pBAD AS24 
shpB-1 
this paper 
pBAD LT2 shpAB bla::spec pBAD LT2 
shpAB-1 
this paper 
pBAD AS24 shpAB bla::spec pBAD AS24 
shpAB-1 
this paper 
pBAD shpA bla::spec pBAD shpA-2 this paper 
pBAD LT2 shpB bla::spec pBAD LT2 
shpB-2 
this paper 
pBAD AS24 shpB bla::spec pBAD AS24 
shpB-2 
this paper 
pSHP prom. shpAB promoter amplified 
from LT2 
pCR2.1 this paper 
pSHP-lacZ NheI fragment from pSHP 
prom. 
pLacZ2 this paper 
Table 2.2.  Continued. 
  
Figure 2.1.  Screening for high persistence.
persistence using the spot assay described in Materials and Methods.  Controls in the top row 
(left to right, in duplicate): LT2, AS26, AV38.  
are circled. 
 
Strain Ampicillin Piperacillin
  (µg/ml) 
LT2 1 
AS13 0.75 
AS17 1 
AS18 1 
Figure 2.2.  Minimum inhibitory concentration determination. 
plate spread with wild type LT2 and antibiotic test strips were applied as described in 
Materials and Methods.  MIC values were determined as the point where bacterial growth 
inhibition intersected with each strip, as shown by the arrows.  A: chloramphenicol; B: 
ampicillin; C: amoxicillin; D: ofloxa
high persisting mutants determined using antibiotic strip method.
 
  Small aliquots of cultures were tested for high 
Transductants that have lost high persistence 
 
 Amoxicillin Chloramphenicol 
(µg/ml) (µg/ml) (µg/ml) 
1.5 - 2 1.5 - 2 3 - 4 
1.5 - 2 1 4 
1.5 - 2 3 3 - 4 
1.5 - 2 2 4 
 Top: A Mueller
cin; E: piperacillin.  Bottom: MIC values of LT2 and 
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Ofloxacin 
(µg/ml) 
0.125-0.19 
0.25-0.38 
0.125-0.19 
0.125-0.19 
-Hinton II 
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LT2 1.98 35
AS13 1.86 37
AS17 2.11 33
AS18 1.85 37
 
Figure 2.3.  Growth curves and the growth rate constants of Salmonella Typhimurium 
strains.  LT2 (diamonds), shp mutants: AS13 (squares), AS17 (triangles), and AS18 
(circles).  Growth was measured as described in Materials and Methods.  The OD600 was 
measured at various times during the growth of each strain. 
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Figure 2.4.  Delay in growth of LT2 and shp high persistent strains.  Overnight cultures 
of LT2 (diamonds), AS13 (squares), AS17 (triangles) and AS18 (circles) were diluted and 
plated on LB and incubated at 37ºC.  The observable colonies were counted at various times 
and compared to the total number observable after 80 hrs. 
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Figure 2.5.  Change in the level of persistence of Salmonella Typhimurium strains in 
response to antibiotics.  Ampicillin, ofloxacin, kanamycin, chloramphenicol, piperacillin 
and ampicillin in agar plates were tested as shown.  Persistence was measured according to 
Materials and Methods. 
 
 
Figure 2.6.  The effect of growth phase on persistence.  As described in Materials and 
Methods, aliquots of cultures during different phases of cell growth were plated on LB plates 
(squares) after 4.5 hrs. of incubation with ampicillin (circles) or ofloxacin (triangles) in order 
to measure the number of persisters. 
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Figure 2.7.  The effect of growth phase on persistence.  Aliquots of growing cells were 
taken at different times and plated on LB plates to measure total CFU/ml (squares).  Aliquots 
were also plated on LB + ampicillin plates to assay the number of persisters (circles) as 
described in Materials and Methods. 
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Figure 2.8.  The effect of relA deletions on the level of persistence in LT2 and shp 
mutant strains. 
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High persister 
strain Marker strain Nearby gene Insertion site 
Percentage of 
cotransduction 
AS13 
AS19 stcC 2245335 7.72 
AS20 yegS 2234789 11.81 
AV16 yegE 2209661 8.0 ± 0.5 
AV49 baeR 2226400 1.2 
AV28 yegD 2214183 7.8 
AV52 yegV 2239570 22.6 
AV50 metG 2251814 96.4 
AV51 STM2161 2257141 40.5 
AS17 
AS26/AV1 hsdM 4779060 9.3 ± 0.3 
AV19 yjiJ 4768845 6.1 
AV31 yeeN 4752473 9.6 
AV40 STM4502 4757122 3.6 
AV39 trpS2 4763105 4.8 
AV45 STM4518 4773401 19.3 
AV38 mrr 4785411 91.7 
AV37 STM4535 4794881 14.5 
AS18 
AS23 STM4536 4795041 11.1 ± 2.8 
AS24 hsdM 4779059 19.3 ± 12.2 
AV17 yjiJ 4768847 2.0 ± 2.8 
AV44 trpS2 4763105 7.1 
AV42 STM4518 4773401 10.7 
AV43 mrr 4785411 96.4 
Table 2.3.  Linkage analysis of Tn10d strains and recombineered strains.  Antibiotic 
markers were inserted in close proximity to the predicted location of the shp mutations 
initially either by random insertion of Tn10d or via recombineering.  The frequency at which 
those antibiotic markers were cotransduced with the high persistence phenotype by 
bacteriophage P22 transduction as described in Materials and Methods is shown.  Strains are 
organized based on the shp mutant strain from which they were derived.  The insertion sites 
in the genomic site at which the Tn10d or recombineered DNA inserted at. 
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Figure 2.9.  Summary of the chromosomal location of shp alleles and recombineering 
strategies.  Top: Map of AS13 genome in the vicinity of metG. Bottom: Map of AS17 and 
AS18 genomes in the vicinity of shpAB.  A KanR marker was used to replace the 
chromosomal regions by recombineering, as shown in the middle.  The region between yehR 
and STM2161 from AS13 was deleted (top) and STM4528 and STM4534 were deleted from 
AS17 and AS18 (bottom).  Length of DNA is not to scale. 
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Figure 2.10.  Complementation of metG418.  The levels of persistence LT2 (wild type) and 
AS20 (metG418) along with a plasmid control as described in Materials and Methods. 
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Figure 2.11.  Persistence levels of deletion mutants.  Regions of chromosome between 
shpA and STM4535 or of shpAB were deleted in LT2, and the shpB1 mutants AS17 and 
AS18.  Deletions were made by recombineering as described in Materials and Methods. 
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Figure 2.12.  Complementation of shpAB1.  The levels of persistence in LT2 and AS24 
when expressing shpAB or shpAB1 under their native promoter or a plasmid control 
(pSMART-LCKan) were measured as described in Materials and Methods and shown on the 
abscissa. 
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Figure 2.13.  The shpB1 mutation.  The C to T transition mutation results in a nonsense 
mutation resulting in a truncation of the C-terminal QNKK residues of ShpB.  Top: 
chromosomal region of AS24, middle: shpAB, bottom: DNA sequence following the mutated 
thymine showing the truncated residues. 
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Figure 2.14.  Persistence levels of mutants transformed with plasmids expressing shpAB 
alleles under araBAD regulation.  AS24 (shpB1) AV53 (ΔshpAB) were transformed 
pBADtopo-derivative plasmids expressing shpAB, shpAB1, shpB or shpB1 as shown.  
Persistence was measured in the absence of arabinose according to Materials and Methods. 
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Figure 2.15.  Persistence levels in strains expressing shpA under araBAD control.  LT2 
(wild type) and AS24 (shpB1) were transformed with plasmids expressing shpA (grey) or a 
control plasmid (white).  Persistence was measured as described in Materials and Methods. 
 
 
Figure 2.16.  Effects of expression of shpAB alleles on growth of S. Typhimurium.  
Strain AV53 (ΔshpAB) was transformed with pBADtopo-derivative plasmids expressing 
shpAB+ (top panel), shpAB1 (second panel), shpB+ (third panel) and shpA+ (bottom panel) 
either in the presence of glucose or arabinose, as indicated. 
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  Stationary cells Mid-Log cells 
Strain Miller units 
Standard 
deviation Miller units 
Standard 
deviation 
LT2 3110 2376 561 337 
AV53 13140 4484 3874 673 
AS24 30226 4812 5390 3660 
Table 2.4.  Promoter activity of shpAB as measured by β-galactosidase activity.  The β-
galactosidase activity was measured from cells in stationary or in mid-log phase.  Assays 
were performed on LT2, AV53 or AS24 transformed with a plasmid expressing lacZ under 
the control of the shpAB promoter. 
 
Homologous 
TA module Salmonella genes 
relBE STM1551/STM1550 
relBE STM3517/STM3516 
relBE STM4449/STM4450 
parDE STM2955.S/STM2954.2N 
higBA STM3907/STM3906 
higBA STM4033/STM4032.2N 
vapBC STM3034/STM3033 
phd/doc yhhV/STM3558 
Table 2.5. Salmonella genes homologous to other TA modules (69). 
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Gene Score 
Predicted 
Homologous 
Genes 
STM4450 96.17 relE 
STM1550 94.57 relE 
STM2954.1n 94.23 parE 
STM1551 92.69 stbD 
STM4449 91.88 relB 
STM3034 91.24 vagC 
STM3033 89.25 vapC 
yhhV 88.26 stbD 
STM2955.S 87.93  
STM3558 87.62 doc 
yfeC 83.67  
yfeD 82.33  
STM3517 81.18 relB 
STM4033 81.16  
STM0898A 80.21  
STM2374 78.71  
yjeK 75.90 stbC 
ybfE 73.85  
STM3907 72.90  
STM4030.S 72.59  
STM1012 72.46  
STM2628 72.46  
STM3778 72.21  
STM2748 72.10  
STM2195 70.53  
STM3516 70.07  
STM4528 51.60  
STM4529 27.00   
Table 2.6.  Prediction of TA modules in Salmonella Typhimurium by the RASTA-
bacteria program.  Genes predicted by the RASTA-bacteria prediction program with a 
score above 70, signifying a high likelihood of being a TA module gene, as well as the scores 
of shpAB (STM4528/29). 
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GENERAL CONCLUSION 
Persistence enables bacteria to better survive lethal changes, including exposure to 
antibiotics.  Since only a relatively small subpopulation of cells within a bacterial culture 
enter into a state of persistence, identifying the molecular mechanisms of persistence has 
proven difficult.  For this reason, we have pursued a genetic approach to isolate mutants that 
exhibit increased levels of persistence in order to study this phenotype. 
We chose to characterize persistence in the pathogen Salmonella enterica serovar 
Typhimurium.  In addition to being a leading cause of food borne illnesses, new strains 
resistant to multiple antibiotics have recently appeared.  Since persistence has important 
implications for use of antibiotics and antiseptics, and may contribute to antibiotic resistance 
by delaying the lethal effects of antimicrobials, determining the molecular mechanisms of 
persistence has important implications for human and animal health.  To this end, we have 
isolated several new mutants of Salmonella Typhimurium that demonstrate higher levels of 
persistence in comparison to wild type.  Similar high persistence mutants of non-pathogenic 
strains of E. coli K-12 have been isolated previously.  However, the hipAB locus responsible 
for this phenotype in E. coli is not found in Salmonella Typhimurium. 
Since E. coli hipAB mutants result from gain of function mutations, we chose to use a 
chemical mutagenesis to isolate new Salmonella mutants, rather than rely on more 
conventional transposon mutagenesis.  While this approach ensured that a wide variety of 
mutant alleles were generated, mapping the mutations is a greater challenge. 
We attempted to identify the genes responsible for the phenotype in six mutants by 
first isolating transposon insertion mutants genetically linked to high persistence.  We 
successfully isolated Tn10d linked to high persistence in three of the Salmonella mutants. 
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The remaining mutants may represent strains that carry multiple mutations, and were not 
further characterized. 
To further identify the locations of the transposon insertions, we used the technique of 
recombineering to insert selectable antibiotic resistance markers to create markers that had 
higher linkages to high persistence, and to generate deletion mutants.  Recombineering also 
allowed us to develop a novel technique to map transposons by retrofitting them with a 
conditional R6K origin of replication converting them into a “plasposons”.  This allowed the 
locations to be easily mapped by directly sequencing plasmids generated from restriction 
enzyme digestions of Salmonella genomic DNA.  This strategy should be useful to map the 
location of transposable elements generated from previous studies in both Salmonella and E. 
coli. 
After identifying the general region of the chromosome to within 2 min. of the 
genetic map or 80-kbp, recombineering was used to insert additional selectable markers to 
increase the linkage with the high persistence genes.  After taking this approach it became 
evident that the linkage relationships between antibiotic resistance and high persistence did 
not accurately reflect the physical distance between the genes, requiring us to saturate the 2 
min. region with markers.  This was likely due to either changes in efficiency of growth or 
infection of bacteriophage P22, or with the variability of the high persistent phenotype. 
Nonetheless, the strategy of introducing additional selectable markers into the 
Salmonella chromosome closely linked to the genes responsible for high persistence did 
eventually yield markers close to the shp mutants.  Utilizing recombineering, we generated 
deletion mutants to specifically identify the genes responsible for the high persistence 
phenotype.  Unfortunately, given the unique nature of this phenotype, we were seldom able 
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to predict which genes in the vicinity of a linked maker could give rise to high persistence.  
For example, baeRS encodes a two-component regulatory system related to antimicrobial 
stress responses.  It is plausible that this locus could yield high persistence by regulation of 
other genes, as has been observed with phoU.  Although initial linkage data suggested that a 
shp mutation was within these genes, deletion of baeRS showed no effect on persistence and 
reevaluation of the linkage confirmed the error in the initial linkages.  Likewise, several open 
reading frames of unknown function in the vicinity of metG could have yielded high 
persistence, yet their deletion also did not alter persistence in the mutants, leading us to 
identify the mutation in metG418. 
Despite these challenges, genes responsible for high persistence for the three mutants 
were identified.  First, the mutant AS13 achieved high persistence by alteration of metG.  The 
product of metG is methionyl-tRNA synthetase, an essential bacterial gene.  Although this 
gene could not be deleted, complementation tests showed that expression of wild type metG 
reduced persistence to wild type levels.  Sequencing the metG418 allele revealed the 
mutation created a truncated protein lacking a portion of the C-terminal domain (CTD).  The 
CTD is known to be responsible for dimerization of the enzyme, additional binding to tRNA, 
as well as possible translational regulation of the metG mRNA (11, 21, 22). 
How this mutation results in high persistence is unknown.  It is possible that the loss 
of the CTD domain destabilizes the protein.  Alternatively, the loss of dimerization, which 
lowers the Km of tRNA binding at low concentration of enzyme, likely results in reduced 
levels of Met-tRNAMet that may slow initiation or elongation of protein synthesis (21).  The 
effects of the mutant MetG must be subtle however, since growth of the metG418 mutant in 
exponential phase is not significantly different from wild type. 
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Consequently, we propose that this alteration has an indirect effect on persistence.  
For example, it is plausible that changes in protein synthetic capacity could trigger 
expression of a stress response, resulting in elevated persistence.  This hypothesis could be 
tested using proteomics or transcriptional profiling to identify other genes whose expression 
is upregulated in the mutant.  Furthermore, determining the levels of both Met-tRNA and 
fMet-tRNA would show whether persistence was caused by initiation or elongation of 
protein synthesis or by some regulatory function of MetG. 
The other two high persistent mutants contained the same mutation.  The shpAB locus 
appears to represent a new toxin/antitoxin (TA) module in salmonella.  Interestingly, 
mutations in hipAB, also encoding a TA module, result in increased persistence in E. coli K-
12.  The TA module identified in this study was named shpAB, for Salmonella high 
persistence and represent the first example of TA genes participating in persistence outside of 
E. coli K-12.  While shpAB is not found in E. coli, hipAB is also not found in Salmonella.  
This is likely reflective of the diverse origins of these genes.  Furthermore, this supports the 
utility of studying persistence in a variety of bacteria other than E. coli. 
Both of these Salmonella high persistence mutants were the result of a nonsense 
mutation in shpB1, resulting in the deletion of the terminal 4 amino acids from the predicted 
gene product.  Through complementation tests, we found the ShpB protein to be the antitoxin 
and ShpA to be the toxin in this new TA module.  In addition, through the use of a lacZ gene 
fusion we confirmed that shpAB is autoregulated, similar to other TA systems. 
From these results we propose a model where high persistence results from an 
imbalance of the ratio of toxin to antitoxin.  The shpB1 mutation could reduce the affinity of 
the antitoxin for the toxin, or result in an unstable gene product.  In either event, we predict 
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that the levels of free toxin will be elevated in the high persistent mutants resulting in a delay 
of growth for a subpopulation of mutant cells.  Under normal conditions, we propose that a 
defined ratio of toxin to antitoxin protein limits the number of cells that enter into a state of 
persistence.  Upon encountering an environmental stress, including antibiotic exposure, the 
levels of the antitoxin protein are reduced, resulting in a growth inhibition due to excess 
toxin.  The imbalance of toxin to antitoxin appears to occur stochastically in a bacterial 
culture, as persistent cells are found in all bacterial populations.  The shpAB mutants have 
apparently altered the balance of toxin to antitoxin resulting in formation of higher numbers 
of persistent cells. 
Future studies will be required to better understand how shpAB contributes to 
persistence in Salmonella, including identifying the target of ShpA.  This could be achieved 
through a molecular strategy such as looking for mutations that reduce toxicity of ShpA.  
Alternatively, a biochemical approach could be used identify the pathway of macromolecular 
synthesis that is disrupted by toxin expression.  Cellular processes such as transcription or 
translation are typically the targets of toxin proteins.  Biochemical approaches will also be 
required to test the hypothesis that ShpA and ShpB interact in vivo and serve to regulate their 
own synthesis. 
Our results also suggest that there are additional TA modules that remain to be 
identified in the Salmonella genome.  A combination of bioinformatics and genetics could be 
used to delete all known as well as newly discovered TA modules before again testing for 
persistence.  While this represents a considerable effort, the fact that multiple TA modules 
exist throughout the genome suggests redundancy in their function.  In any case, their 
function must be important for bacteria to maintain toxic proteins with the ability to limit 
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growth.  The potential role of TA modules in disease should also be tested using animal 
models.  These insights from continued study of persistence in Salmonella will likely be 
applicable to all bacteria.
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